id	sid	tid	token	lemma	pos
cord-026803-p1o4qc1h	1	1	key	key	JJ
cord-026803-p1o4qc1h	2	1	:	:	:
cord-026803-p1o4qc1h	2	2	cord-026803-p1o4qc1h	cord-026803-p1o4qc1h	NNP
cord-026803-p1o4qc1h	2	3	authors	author	NNS
cord-026803-p1o4qc1h	2	4	:	:	:
cord-026803-p1o4qc1h	2	5	Maddury	Maddury	NNP
cord-026803-p1o4qc1h	2	6	,	,	,
cord-026803-p1o4qc1h	2	7	Jyotsna	Jyotsna	NNP
cord-026803-p1o4qc1h	2	8	;	;	.
cord-026803-p1o4qc1h	3	1	Paramjyothi	Paramjyothi	NNP
cord-026803-p1o4qc1h	3	2	,	,	,
cord-026803-p1o4qc1h	3	3	G.	G.	NNP
cord-026803-p1o4qc1h	3	4	K.	K.	NNP
cord-026803-p1o4qc1h	4	1	title	title	NN
cord-026803-p1o4qc1h	4	2	:	:	:
cord-026803-p1o4qc1h	4	3	Need	need	NN
cord-026803-p1o4qc1h	4	4	of	of	IN
cord-026803-p1o4qc1h	4	5	the	the	DT
cord-026803-p1o4qc1h	4	6	Hour	Hour	NNP
cord-026803-p1o4qc1h	4	7	—	—	:
cord-026803-p1o4qc1h	4	8	COVID-19	covid-19	VB
cord-026803-p1o4qc1h	4	9	for	for	IN
cord-026803-p1o4qc1h	4	10	Cardiologists	cardiologist	NNS
cord-026803-p1o4qc1h	4	11	date	date	NN
cord-026803-p1o4qc1h	4	12	:	:	:
cord-026803-p1o4qc1h	4	13	2020	2020	CD
cord-026803-p1o4qc1h	4	14	-	-	HYPH
cord-026803-p1o4qc1h	4	15	04	04	CD
cord-026803-p1o4qc1h	4	16	-	-	HYPH
cord-026803-p1o4qc1h	4	17	16	16	CD
cord-026803-p1o4qc1h	4	18	journal	journal	NN
cord-026803-p1o4qc1h	4	19	:	:	:
cord-026803-p1o4qc1h	5	1	Indian	indian	JJ
cord-026803-p1o4qc1h	5	2	J	J	NNP
cord-026803-p1o4qc1h	5	3	Cardiovasc	Cardiovasc	NNP
cord-026803-p1o4qc1h	5	4	Dis	Dis	NNP
cord-026803-p1o4qc1h	5	5	Women	Women	NNP
cord-026803-p1o4qc1h	5	6	WINCARS	WINCARS	NNP
cord-026803-p1o4qc1h	6	1	DOI	DOI	NNP
cord-026803-p1o4qc1h	6	2	:	:	:
cord-026803-p1o4qc1h	7	1	10.1055	10.1055	CD
cord-026803-p1o4qc1h	7	2	/	/	SYM
cord-026803-p1o4qc1h	7	3	s-0040	s-0040	,
cord-026803-p1o4qc1h	7	4	-	-	HYPH
cord-026803-p1o4qc1h	7	5	1709950	1709950	CD
cord-026803-p1o4qc1h	7	6	sha	sha	NNP
cord-026803-p1o4qc1h	7	7	:	:	:
cord-026803-p1o4qc1h	7	8	9b1ff27498c10cefc1cb54b69c8706aada8340f9	9b1ff27498c10cefc1cb54b69c8706aada8340f9	CD
cord-026803-p1o4qc1h	7	9	doc_id	doc_id	CD
cord-026803-p1o4qc1h	7	10	:	:	:
cord-026803-p1o4qc1h	7	11	26803	26803	CD
cord-026803-p1o4qc1h	7	12	cord_uid	cord_uid	NNS
cord-026803-p1o4qc1h	7	13	:	:	:
cord-026803-p1o4qc1h	7	14	p1o4qc1h	p1o4qc1h	NNP
cord-026803-p1o4qc1h	7	15	nan	nan	NNP
cord-026803-p1o4qc1h	8	1	The	the	DT
cord-026803-p1o4qc1h	8	2	most	most	RBS
cord-026803-p1o4qc1h	8	3	distressing	distressing	JJ
cord-026803-p1o4qc1h	8	4	pandemic	pandemic	NN
cord-026803-p1o4qc1h	8	5	at	at	IN
cord-026803-p1o4qc1h	8	6	present	present	NN
cord-026803-p1o4qc1h	8	7	is	be	VBZ
cord-026803-p1o4qc1h	8	8	coronavirus	coronavirus	NN
cord-026803-p1o4qc1h	8	9	disease	disease	NN
cord-026803-p1o4qc1h	8	10	2019	2019	CD
cord-026803-p1o4qc1h	8	11	,	,	,
cord-026803-p1o4qc1h	8	12	caused	cause	VBN
cord-026803-p1o4qc1h	8	13	by	by	IN
cord-026803-p1o4qc1h	8	14	severe	severe	JJ
cord-026803-p1o4qc1h	8	15	acute	acute	JJ
cord-026803-p1o4qc1h	8	16	respiratory	respiratory	JJ
cord-026803-p1o4qc1h	8	17	syndrome	syndrome	NN
cord-026803-p1o4qc1h	8	18	coronavirus	coronavirus	NN
cord-026803-p1o4qc1h	8	19	2	2	CD
cord-026803-p1o4qc1h	9	1	(	(	-LRB-
cord-026803-p1o4qc1h	9	2	SARS	SARS	NNP
cord-026803-p1o4qc1h	9	3	-	-	HYPH
cord-026803-p1o4qc1h	9	4	CoV-2	CoV-2	NNP
cord-026803-p1o4qc1h	9	5	)	)	-RRB-
cord-026803-p1o4qc1h	9	6	.	.	.
cord-026803-p1o4qc1h	10	1	1	1	LS
cord-026803-p1o4qc1h	11	1	Even	even	RB
cord-026803-p1o4qc1h	11	2	though	though	IN
cord-026803-p1o4qc1h	11	3	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	11	4	predominantly	predominantly	RB
cord-026803-p1o4qc1h	11	5	affects	affect	VBZ
cord-026803-p1o4qc1h	11	6	the	the	DT
cord-026803-p1o4qc1h	11	7	lungs	lung	NNS
cord-026803-p1o4qc1h	11	8	by	by	IN
cord-026803-p1o4qc1h	11	9	causing	cause	VBG
cord-026803-p1o4qc1h	11	10	acute	acute	JJ
cord-026803-p1o4qc1h	11	11	respiratory	respiratory	JJ
cord-026803-p1o4qc1h	11	12	distress	distress	NN
cord-026803-p1o4qc1h	11	13	syndrome	syndrome	NN
cord-026803-p1o4qc1h	11	14	,	,	,
cord-026803-p1o4qc1h	11	15	the	the	DT
cord-026803-p1o4qc1h	11	16	heart	heart	NN
cord-026803-p1o4qc1h	11	17	is	be	VBZ
cord-026803-p1o4qc1h	11	18	not	not	RB
cord-026803-p1o4qc1h	11	19	completely	completely	RB
cord-026803-p1o4qc1h	11	20	spared	spare	VBN
cord-026803-p1o4qc1h	11	21	.	.	.
cord-026803-p1o4qc1h	12	1	People	People	NNS
cord-026803-p1o4qc1h	12	2	with	with	IN
cord-026803-p1o4qc1h	12	3	underlying	underlie	VBG
cord-026803-p1o4qc1h	12	4	heart	heart	NN
cord-026803-p1o4qc1h	12	5	disease	disease	NN
cord-026803-p1o4qc1h	12	6	are	be	VBP
cord-026803-p1o4qc1h	12	7	at	at	IN
cord-026803-p1o4qc1h	12	8	risk	risk	NN
cord-026803-p1o4qc1h	12	9	.	.	.
cord-026803-p1o4qc1h	13	1	The	the	DT
cord-026803-p1o4qc1h	13	2	main	main	JJ
cord-026803-p1o4qc1h	13	3	aim	aim	NN
cord-026803-p1o4qc1h	13	4	of	of	IN
cord-026803-p1o4qc1h	13	5	this	this	DT
cord-026803-p1o4qc1h	13	6	article	article	NN
cord-026803-p1o4qc1h	13	7	is	be	VBZ
cord-026803-p1o4qc1h	13	8	to	to	TO
cord-026803-p1o4qc1h	13	9	summarize	summarize	VB
cord-026803-p1o4qc1h	13	10	the	the	DT
cord-026803-p1o4qc1h	13	11	available	available	JJ
cord-026803-p1o4qc1h	13	12	evidence	evidence	NN
cord-026803-p1o4qc1h	13	13	of	of	IN
cord-026803-p1o4qc1h	13	14	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	13	15	involvement	involvement	NN
cord-026803-p1o4qc1h	13	16	in	in	IN
cord-026803-p1o4qc1h	13	17	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	13	18	patients	patient	NNS
cord-026803-p1o4qc1h	13	19	and	and	CC
cord-026803-p1o4qc1h	13	20	outlay	outlay	VB
cord-026803-p1o4qc1h	13	21	precautions	precaution	NNS
cord-026803-p1o4qc1h	13	22	to	to	IN
cord-026803-p1o4qc1h	13	23	patients	patient	NNS
cord-026803-p1o4qc1h	13	24	with	with	IN
cord-026803-p1o4qc1h	13	25	underlying	underlying	JJ
cord-026803-p1o4qc1h	13	26	cardiovascular	cardiovascular	JJ
cord-026803-p1o4qc1h	13	27	disease	disease	NN
cord-026803-p1o4qc1h	13	28	(	(	-LRB-
cord-026803-p1o4qc1h	13	29	CVD	CVD	NNP
cord-026803-p1o4qc1h	13	30	)	)	-RRB-
cord-026803-p1o4qc1h	13	31	.	.	.
cord-026803-p1o4qc1h	14	1	People	People	NNS
cord-026803-p1o4qc1h	14	2	with	with	IN
cord-026803-p1o4qc1h	14	3	the	the	DT
cord-026803-p1o4qc1h	14	4	cardiopulmonary	cardiopulmonary	JJ
cord-026803-p1o4qc1h	14	5	disease	disease	NN
cord-026803-p1o4qc1h	14	6	are	be	VBP
cord-026803-p1o4qc1h	14	7	at	at	IN
cord-026803-p1o4qc1h	14	8	higher	high	JJR
cord-026803-p1o4qc1h	14	9	risk	risk	NN
cord-026803-p1o4qc1h	14	10	.	.	.
cord-026803-p1o4qc1h	15	1	As	as	IN
cord-026803-p1o4qc1h	15	2	the	the	DT
cord-026803-p1o4qc1h	15	3	virus	virus	NN
cord-026803-p1o4qc1h	15	4	survives	survive	VBZ
cord-026803-p1o4qc1h	15	5	in	in	IN
cord-026803-p1o4qc1h	15	6	low	low	JJ
cord-026803-p1o4qc1h	15	7	temperatures	temperature	NNS
cord-026803-p1o4qc1h	15	8	,	,	,
cord-026803-p1o4qc1h	15	9	nose	nose	NN
cord-026803-p1o4qc1h	15	10	and	and	CC
cord-026803-p1o4qc1h	15	11	sinuses	sinus	NNS
cord-026803-p1o4qc1h	15	12	are	be	VBP
cord-026803-p1o4qc1h	15	13	the	the	DT
cord-026803-p1o4qc1h	15	14	main	main	JJ
cord-026803-p1o4qc1h	15	15	sources	source	NNS
cord-026803-p1o4qc1h	15	16	of	of	IN
cord-026803-p1o4qc1h	15	17	infection	infection	NN
cord-026803-p1o4qc1h	15	18	.	.	.
cord-026803-p1o4qc1h	16	1	This	this	DT
cord-026803-p1o4qc1h	16	2	virus	virus	NN
cord-026803-p1o4qc1h	16	3	could	could	MD
cord-026803-p1o4qc1h	16	4	affect	affect	VB
cord-026803-p1o4qc1h	16	5	the	the	DT
cord-026803-p1o4qc1h	16	6	heart	heart	NN
cord-026803-p1o4qc1h	16	7	,	,	,
cord-026803-p1o4qc1h	16	8	especially	especially	RB
cord-026803-p1o4qc1h	16	9	a	a	DT
cord-026803-p1o4qc1h	16	10	diseased	diseased	JJ
cord-026803-p1o4qc1h	16	11	heart	heart	NN
cord-026803-p1o4qc1h	16	12	.	.	.
cord-026803-p1o4qc1h	17	1	Although	although	IN
cord-026803-p1o4qc1h	17	2	information	information	NN
cord-026803-p1o4qc1h	17	3	about	about	IN
cord-026803-p1o4qc1h	17	4	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	17	5	is	be	VBZ
cord-026803-p1o4qc1h	17	6	changing	change	VBG
cord-026803-p1o4qc1h	17	7	on	on	IN
cord-026803-p1o4qc1h	17	8	an	an	DT
cord-026803-p1o4qc1h	17	9	hourly	hourly	JJ
cord-026803-p1o4qc1h	17	10	basis	basis	NN
cord-026803-p1o4qc1h	17	11	,	,	,
cord-026803-p1o4qc1h	17	12	information	information	NN
cord-026803-p1o4qc1h	17	13	of	of	IN
cord-026803-p1o4qc1h	17	14	the	the	DT
cord-026803-p1o4qc1h	17	15	previous	previous	JJ
cord-026803-p1o4qc1h	17	16	severe	severe	JJ
cord-026803-p1o4qc1h	17	17	acute	acute	JJ
cord-026803-p1o4qc1h	17	18	respiratory	respiratory	JJ
cord-026803-p1o4qc1h	17	19	syndrome	syndrome	NN
cord-026803-p1o4qc1h	17	20	(	(	-LRB-
cord-026803-p1o4qc1h	17	21	SARS	SARS	NNP
cord-026803-p1o4qc1h	17	22	)	)	-RRB-
cord-026803-p1o4qc1h	17	23	and	and	CC
cord-026803-p1o4qc1h	17	24	Middle	Middle	NNP
cord-026803-p1o4qc1h	17	25	East	East	NNP
cord-026803-p1o4qc1h	17	26	respiratory	respiratory	JJ
cord-026803-p1o4qc1h	17	27	syndrome	syndrome	NN
cord-026803-p1o4qc1h	17	28	(	(	-LRB-
cord-026803-p1o4qc1h	17	29	MERS)producing	MERS)producing	NNP
cord-026803-p1o4qc1h	17	30	coronaviruses	coronaviruses	NNP
cord-026803-p1o4qc1h	17	31	offers	offer	VBZ
cord-026803-p1o4qc1h	17	32	insight	insight	NN
cord-026803-p1o4qc1h	17	33	.	.	.
cord-026803-p1o4qc1h	18	1	2	2	LS
cord-026803-p1o4qc1h	19	1	They	-PRON-	PRP
cord-026803-p1o4qc1h	19	2	were	be	VBD
cord-026803-p1o4qc1h	19	3	linked	link	VBN
cord-026803-p1o4qc1h	19	4	to	to	IN
cord-026803-p1o4qc1h	19	5	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	19	6	disease	disease	NN
cord-026803-p1o4qc1h	19	7	as	as	IN
cord-026803-p1o4qc1h	19	8	they	-PRON-	PRP
cord-026803-p1o4qc1h	19	9	produced	produce	VBD
cord-026803-p1o4qc1h	19	10	inflammation	inflammation	NN
cord-026803-p1o4qc1h	19	11	of	of	IN
cord-026803-p1o4qc1h	19	12	the	the	DT
cord-026803-p1o4qc1h	19	13	heart	heart	NN
cord-026803-p1o4qc1h	19	14	muscle	muscle	NN
cord-026803-p1o4qc1h	19	15	,	,	,
cord-026803-p1o4qc1h	19	16	myocardial	myocardial	JJ
cord-026803-p1o4qc1h	19	17	infarction	infarction	NN
cord-026803-p1o4qc1h	19	18	,	,	,
cord-026803-p1o4qc1h	19	19	and	and	CC
cord-026803-p1o4qc1h	19	20	rapid	rapid	JJ
cord-026803-p1o4qc1h	19	21	-	-	HYPH
cord-026803-p1o4qc1h	19	22	onset	onset	NN
cord-026803-p1o4qc1h	19	23	heart	heart	NN
cord-026803-p1o4qc1h	19	24	failure	failure	NN
cord-026803-p1o4qc1h	19	25	.	.	.
cord-026803-p1o4qc1h	20	1	Most	Most	JJS
cord-026803-p1o4qc1h	20	2	of	of	IN
cord-026803-p1o4qc1h	20	3	the	the	DT
cord-026803-p1o4qc1h	20	4	published	publish	VBN
cord-026803-p1o4qc1h	20	5	information	information	NN
cord-026803-p1o4qc1h	20	6	on	on	IN
cord-026803-p1o4qc1h	20	7	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	20	8	is	be	VBZ
cord-026803-p1o4qc1h	20	9	from	from	IN
cord-026803-p1o4qc1h	20	10	China	China	NNP
cord-026803-p1o4qc1h	20	11	.	.	.
cord-026803-p1o4qc1h	21	1	Three	three	CD
cord-026803-p1o4qc1h	21	2	important	important	JJ
cord-026803-p1o4qc1h	21	3	publications	publication	NNS
cord-026803-p1o4qc1h	21	4	in	in	IN
cord-026803-p1o4qc1h	21	5	New	New	NNP
cord-026803-p1o4qc1h	21	6	England	England	NNP
cord-026803-p1o4qc1h	21	7	Journal	Journal	NNP
cord-026803-p1o4qc1h	21	8	of	of	IN
cord-026803-p1o4qc1h	21	9	Medicine	Medicine	NNP
cord-026803-p1o4qc1h	21	10	,	,	,
cord-026803-p1o4qc1h	21	11	Lancet	Lancet	NNP
cord-026803-p1o4qc1h	21	12	,	,	,
cord-026803-p1o4qc1h	21	13	and	and	CC
cord-026803-p1o4qc1h	21	14	Allergy	allergy	NN
cord-026803-p1o4qc1h	21	15	are	be	VBP
cord-026803-p1o4qc1h	21	16	based	base	VBN
cord-026803-p1o4qc1h	21	17	on	on	IN
cord-026803-p1o4qc1h	21	18	the	the	DT
cord-026803-p1o4qc1h	21	19	cases	case	NNS
cord-026803-p1o4qc1h	21	20	from	from	IN
cord-026803-p1o4qc1h	21	21	China	China	NNP
cord-026803-p1o4qc1h	21	22	.	.	.
cord-026803-p1o4qc1h	22	1	[	[	-LRB-
cord-026803-p1o4qc1h	22	2	3	3	CD
cord-026803-p1o4qc1h	22	3	]	]	-RRB-
cord-026803-p1o4qc1h	22	4	[	[	-LRB-
cord-026803-p1o4qc1h	22	5	4	4	CD
cord-026803-p1o4qc1h	22	6	]	]	-RRB-
cord-026803-p1o4qc1h	22	7	[	[	-LRB-
cord-026803-p1o4qc1h	22	8	5	5	CD
cord-026803-p1o4qc1h	22	9	]	]	-RRB-
cord-026803-p1o4qc1h	23	1	Even	even	RB
cord-026803-p1o4qc1h	23	2	though	though	IN
cord-026803-p1o4qc1h	23	3	the	the	DT
cord-026803-p1o4qc1h	23	4	initial	initial	JJ
cord-026803-p1o4qc1h	23	5	study	study	NN
cord-026803-p1o4qc1h	23	6	published	publish	VBN
cord-026803-p1o4qc1h	23	7	in	in	IN
cord-026803-p1o4qc1h	23	8	Lancet	Lancet	NNP
cord-026803-p1o4qc1h	23	9	showed	show	VBD
cord-026803-p1o4qc1h	23	10	male	male	JJ
cord-026803-p1o4qc1h	23	11	preponderance	preponderance	NN
cord-026803-p1o4qc1h	23	12	(	(	-LRB-
cord-026803-p1o4qc1h	23	13	70	70	CD
cord-026803-p1o4qc1h	23	14	%	%	NN
cord-026803-p1o4qc1h	23	15	males	male	NNS
cord-026803-p1o4qc1h	23	16	)	)	-RRB-
cord-026803-p1o4qc1h	23	17	,	,	,
cord-026803-p1o4qc1h	23	18	in	in	IN
cord-026803-p1o4qc1h	23	19	a	a	DT
cord-026803-p1o4qc1h	23	20	short	short	JJ
cord-026803-p1o4qc1h	23	21	duration	duration	NN
cord-026803-p1o4qc1h	23	22	another	another	DT
cord-026803-p1o4qc1h	23	23	publication	publication	NN
cord-026803-p1o4qc1h	23	24	in	in	IN
cord-026803-p1o4qc1h	23	25	Allergy	allergy	NN
cord-026803-p1o4qc1h	23	26	showed	show	VBD
cord-026803-p1o4qc1h	23	27	a	a	DT
cord-026803-p1o4qc1h	23	28	1:1	1:1	CD
cord-026803-p1o4qc1h	23	29	ratio	ratio	NN
cord-026803-p1o4qc1h	23	30	of	of	IN
cord-026803-p1o4qc1h	23	31	male	male	NN
cord-026803-p1o4qc1h	23	32	(	(	-LRB-
cord-026803-p1o4qc1h	23	33	50.7	50.7	CD
cord-026803-p1o4qc1h	23	34	%	%	NN
cord-026803-p1o4qc1h	23	35	)	)	-RRB-
cord-026803-p1o4qc1h	23	36	and	and	CC
cord-026803-p1o4qc1h	23	37	female	female	JJ
cord-026803-p1o4qc1h	23	38	involvement	involvement	NN
cord-026803-p1o4qc1h	23	39	.	.	.
cord-026803-p1o4qc1h	24	1	Initial	initial	JJ
cord-026803-p1o4qc1h	24	2	studies	study	NNS
cord-026803-p1o4qc1h	24	3	showed	show	VBD
cord-026803-p1o4qc1h	24	4	low	low	JJ
cord-026803-p1o4qc1h	24	5	association	association	NNP
cord-026803-p1o4qc1h	24	6	of	of	IN
cord-026803-p1o4qc1h	24	7	chronic	chronic	NNP
cord-026803-p1o4qc1h	24	8	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	24	9	diseases	disease	NNS
cord-026803-p1o4qc1h	24	10	(	(	-LRB-
cord-026803-p1o4qc1h	24	11	10	10	CD
cord-026803-p1o4qc1h	24	12	%	%	NN
cord-026803-p1o4qc1h	24	13	)	)	-RRB-
cord-026803-p1o4qc1h	24	14	in	in	IN
cord-026803-p1o4qc1h	24	15	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	24	16	patients	patient	NNS
cord-026803-p1o4qc1h	24	17	along	along	IN
cord-026803-p1o4qc1h	24	18	with	with	IN
cord-026803-p1o4qc1h	24	19	the	the	DT
cord-026803-p1o4qc1h	24	20	acute	acute	JJ
cord-026803-p1o4qc1h	24	21	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	24	22	injury	injury	NN
cord-026803-p1o4qc1h	24	23	accounting	account	VBG
cord-026803-p1o4qc1h	24	24	to	to	IN
cord-026803-p1o4qc1h	24	25	23	23	CD
cord-026803-p1o4qc1h	24	26	%	%	NN
cord-026803-p1o4qc1h	24	27	.	.	.
cord-026803-p1o4qc1h	25	1	Acute	acute	JJ
cord-026803-p1o4qc1h	25	2	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	25	3	injury	injury	NN
cord-026803-p1o4qc1h	25	4	was	be	VBD
cord-026803-p1o4qc1h	25	5	diagnosed	diagnose	VBN
cord-026803-p1o4qc1h	25	6	when	when	WRB
cord-026803-p1o4qc1h	25	7	hypersensitive	hypersensitive	JJ
cord-026803-p1o4qc1h	25	8	cardiac	cardiac	NN
cord-026803-p1o4qc1h	25	9	troponin	troponin	NN
cord-026803-p1o4qc1h	25	10	I	-PRON-	PRP
cord-026803-p1o4qc1h	25	11	was	be	VBD
cord-026803-p1o4qc1h	25	12	>	>	NFP
cord-026803-p1o4qc1h	25	13	28	28	CD
cord-026803-p1o4qc1h	25	14	pg	pg	NNP
cord-026803-p1o4qc1h	25	15	/	/	SYM
cord-026803-p1o4qc1h	25	16	mL.	mL.	NNP
cord-026803-p1o4qc1h	25	17	Recent	recent	JJ
cord-026803-p1o4qc1h	25	18	studies	study	NNS
cord-026803-p1o4qc1h	25	19	have	have	VBP
cord-026803-p1o4qc1h	25	20	showed	show	VBN
cord-026803-p1o4qc1h	25	21	increased	increase	VBN
cord-026803-p1o4qc1h	25	22	association	association	NN
cord-026803-p1o4qc1h	25	23	of	of	IN
cord-026803-p1o4qc1h	25	24	CVD	CVD	NNP
cord-026803-p1o4qc1h	25	25	,	,	,
cord-026803-p1o4qc1h	25	26	up	up	IN
cord-026803-p1o4qc1h	25	27	to	to	TO
cord-026803-p1o4qc1h	25	28	40	40	CD
cord-026803-p1o4qc1h	25	29	%	%	NN
cord-026803-p1o4qc1h	25	30	,	,	,
cord-026803-p1o4qc1h	25	31	in	in	IN
cord-026803-p1o4qc1h	25	32	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	25	33	patients	patient	NNS
cord-026803-p1o4qc1h	25	34	.	.	.
cord-026803-p1o4qc1h	26	1	But	but	CC
cord-026803-p1o4qc1h	26	2	more	more	JJR
cord-026803-p1o4qc1h	26	3	recent	recent	JJ
cord-026803-p1o4qc1h	26	4	studies	study	NNS
cord-026803-p1o4qc1h	26	5	have	have	VBP
cord-026803-p1o4qc1h	26	6	showed	show	VBN
cord-026803-p1o4qc1h	26	7	increased	increase	VBN
cord-026803-p1o4qc1h	26	8	association	association	NN
cord-026803-p1o4qc1h	26	9	of	of	IN
cord-026803-p1o4qc1h	26	10	CVD	CVD	NNP
cord-026803-p1o4qc1h	26	11	,	,	,
cord-026803-p1o4qc1h	26	12	up	up	IN
cord-026803-p1o4qc1h	26	13	to	to	TO
cord-026803-p1o4qc1h	26	14	40	40	CD
cord-026803-p1o4qc1h	26	15	%	%	NN
cord-026803-p1o4qc1h	26	16	,	,	,
cord-026803-p1o4qc1h	26	17	in	in	IN
cord-026803-p1o4qc1h	26	18	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	26	19	patients	patient	NNS
cord-026803-p1o4qc1h	26	20	.	.	.
cord-026803-p1o4qc1h	27	1	Fifty	fifty	CD
cord-026803-p1o4qc1h	27	2	percent	percent	NN
cord-026803-p1o4qc1h	27	3	of	of	IN
cord-026803-p1o4qc1h	27	4	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	27	5	patients	patient	NNS
cord-026803-p1o4qc1h	27	6	had	have	VBD
cord-026803-p1o4qc1h	27	7	comorbidities	comorbiditie	NNS
cord-026803-p1o4qc1h	27	8	,	,	,
cord-026803-p1o4qc1h	27	9	most	most	RBS
cord-026803-p1o4qc1h	27	10	common	common	JJ
cord-026803-p1o4qc1h	27	11	was	be	VBD
cord-026803-p1o4qc1h	27	12	hypertension	hypertension	NN
cord-026803-p1o4qc1h	27	13	(	(	-LRB-
cord-026803-p1o4qc1h	27	14	in	in	IN
cord-026803-p1o4qc1h	27	15	30	30	CD
cord-026803-p1o4qc1h	27	16	%	%	NN
cord-026803-p1o4qc1h	27	17	)	)	-RRB-
cord-026803-p1o4qc1h	27	18	,	,	,
cord-026803-p1o4qc1h	27	19	diabetes	diabetes	NN
cord-026803-p1o4qc1h	27	20	(	(	-LRB-
cord-026803-p1o4qc1h	27	21	in	in	IN
cord-026803-p1o4qc1h	27	22	19	19	CD
cord-026803-p1o4qc1h	27	23	%	%	NN
cord-026803-p1o4qc1h	27	24	)	)	-RRB-
cord-026803-p1o4qc1h	27	25	,	,	,
cord-026803-p1o4qc1h	27	26	and	and	CC
cord-026803-p1o4qc1h	27	27	coronary	coronary	JJ
cord-026803-p1o4qc1h	27	28	artery	artery	NN
cord-026803-p1o4qc1h	27	29	disease	disease	NN
cord-026803-p1o4qc1h	27	30	(	(	-LRB-
cord-026803-p1o4qc1h	27	31	in	in	IN
cord-026803-p1o4qc1h	27	32	8	8	CD
cord-026803-p1o4qc1h	27	33	%	%	NN
cord-026803-p1o4qc1h	27	34	)	)	-RRB-
cord-026803-p1o4qc1h	27	35	.	.	.
cord-026803-p1o4qc1h	28	1	This	this	DT
cord-026803-p1o4qc1h	28	2	high	high	JJ
cord-026803-p1o4qc1h	28	3	proportion	proportion	NN
cord-026803-p1o4qc1h	28	4	of	of	IN
cord-026803-p1o4qc1h	28	5	CVD	CVD	NNP
cord-026803-p1o4qc1h	28	6	was	be	VBD
cord-026803-p1o4qc1h	28	7	the	the	DT
cord-026803-p1o4qc1h	28	8	cause	cause	NN
cord-026803-p1o4qc1h	28	9	for	for	IN
cord-026803-p1o4qc1h	28	10	high	high	JJ
cord-026803-p1o4qc1h	28	11	mortality	mortality	NN
cord-026803-p1o4qc1h	28	12	in	in	IN
cord-026803-p1o4qc1h	28	13	patients	patient	NNS
cord-026803-p1o4qc1h	28	14	with	with	IN
cord-026803-p1o4qc1h	28	15	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	28	16	.	.	.
cord-026803-p1o4qc1h	29	1	COVID-19	covid-19	VB
cord-026803-p1o4qc1h	29	2	in	in	IN
cord-026803-p1o4qc1h	29	3	patients	patient	NNS
cord-026803-p1o4qc1h	29	4	with	with	IN
cord-026803-p1o4qc1h	29	5	compensated	compensated	JJ
cord-026803-p1o4qc1h	29	6	heart	heart	NN
cord-026803-p1o4qc1h	29	7	failure	failure	NN
cord-026803-p1o4qc1h	29	8	may	may	MD
cord-026803-p1o4qc1h	29	9	precipitate	precipitate	VB
cord-026803-p1o4qc1h	29	10	heart	heart	NN
cord-026803-p1o4qc1h	29	11	failure	failure	NN
cord-026803-p1o4qc1h	29	12	.	.	.
cord-026803-p1o4qc1h	30	1	6	6	CD
cord-026803-p1o4qc1h	31	1	In	in	IN
cord-026803-p1o4qc1h	31	2	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	31	3	patients	patient	NNS
cord-026803-p1o4qc1h	31	4	cardiovascular	cardiovascular	JJ
cord-026803-p1o4qc1h	31	5	disorders	disorder	NNS
cord-026803-p1o4qc1h	31	6	including	include	VBG
cord-026803-p1o4qc1h	31	7	arrythmias	arrythmia	NNS
cord-026803-p1o4qc1h	31	8	may	may	MD
cord-026803-p1o4qc1h	31	9	occur	occur	VB
cord-026803-p1o4qc1h	31	10	due	due	IN
cord-026803-p1o4qc1h	31	11	to	to	IN
cord-026803-p1o4qc1h	31	12	drug	drug	NN
cord-026803-p1o4qc1h	31	13	therapy	therapy	NN
cord-026803-p1o4qc1h	31	14	for	for	IN
cord-026803-p1o4qc1h	31	15	the	the	DT
cord-026803-p1o4qc1h	31	16	diseases	disease	NNS
cord-026803-p1o4qc1h	31	17	,	,	,
cord-026803-p1o4qc1h	31	18	especially	especially	RB
cord-026803-p1o4qc1h	31	19	the	the	DT
cord-026803-p1o4qc1h	31	20	antiviral	antiviral	JJ
cord-026803-p1o4qc1h	31	21	drugs	drug	NNS
cord-026803-p1o4qc1h	31	22	or	or	CC
cord-026803-p1o4qc1h	31	23	drug	drug	NN
cord-026803-p1o4qc1h	31	24	interactions	interaction	NNS
cord-026803-p1o4qc1h	31	25	.	.	.
cord-026803-p1o4qc1h	32	1	So	so	RB
cord-026803-p1o4qc1h	32	2	,	,	,
cord-026803-p1o4qc1h	32	3	these	these	DT
cord-026803-p1o4qc1h	32	4	patients	patient	NNS
cord-026803-p1o4qc1h	32	5	also	also	RB
cord-026803-p1o4qc1h	32	6	require	require	VBP
cord-026803-p1o4qc1h	32	7	close	close	JJ
cord-026803-p1o4qc1h	32	8	monitoring	monitoring	NN
cord-026803-p1o4qc1h	32	9	.	.	.
cord-026803-p1o4qc1h	33	1	Even	even	RB
cord-026803-p1o4qc1h	33	2	though	though	IN
cord-026803-p1o4qc1h	33	3	the	the	DT
cord-026803-p1o4qc1h	33	4	comorbid	comorbid	NN
cord-026803-p1o4qc1h	33	5	conditions	condition	NNS
cord-026803-p1o4qc1h	33	6	association	association	NNP
cord-026803-p1o4qc1h	33	7	with	with	IN
cord-026803-p1o4qc1h	33	8	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	33	9	was	be	VBD
cord-026803-p1o4qc1h	33	10	high	high	JJ
cord-026803-p1o4qc1h	33	11	,	,	,
cord-026803-p1o4qc1h	33	12	acute	acute	JJ
cord-026803-p1o4qc1h	33	13	myocardial	myocardial	JJ
cord-026803-p1o4qc1h	33	14	infarction	infarction	NN
cord-026803-p1o4qc1h	33	15	was	be	VBD
cord-026803-p1o4qc1h	33	16	reported	report	VBN
cord-026803-p1o4qc1h	33	17	only	only	RB
cord-026803-p1o4qc1h	33	18	in	in	IN
cord-026803-p1o4qc1h	33	19	one	one	CD
cord-026803-p1o4qc1h	33	20	young	young	JJ
cord-026803-p1o4qc1h	33	21	female	female	NN
cord-026803-p1o4qc1h	33	22	who	who	WP
cord-026803-p1o4qc1h	33	23	had	have	VBD
cord-026803-p1o4qc1h	33	24	normal	normal	JJ
cord-026803-p1o4qc1h	33	25	coronaries	coronary	NNS
cord-026803-p1o4qc1h	33	26	on	on	IN
cord-026803-p1o4qc1h	33	27	angiogram	angiogram	NN
cord-026803-p1o4qc1h	33	28	.	.	.
cord-026803-p1o4qc1h	34	1	These	these	DT
cord-026803-p1o4qc1h	34	2	reports	report	NNS
cord-026803-p1o4qc1h	34	3	with	with	IN
cord-026803-p1o4qc1h	34	4	new	new	JJ
cord-026803-p1o4qc1h	34	5	information	information	NN
cord-026803-p1o4qc1h	34	6	urge	urge	VBP
cord-026803-p1o4qc1h	34	7	cardiologists	cardiologist	NNS
cord-026803-p1o4qc1h	34	8	to	to	TO
cord-026803-p1o4qc1h	34	9	warn	warn	VB
cord-026803-p1o4qc1h	34	10	patients	patient	NNS
cord-026803-p1o4qc1h	34	11	about	about	IN
cord-026803-p1o4qc1h	34	12	the	the	DT
cord-026803-p1o4qc1h	34	13	potential	potential	JJ
cord-026803-p1o4qc1h	34	14	risk	risk	NN
cord-026803-p1o4qc1h	34	15	and	and	CC
cord-026803-p1o4qc1h	34	16	encourage	encourage	VB
cord-026803-p1o4qc1h	34	17	them	-PRON-	PRP
cord-026803-p1o4qc1h	34	18	to	to	TO
cord-026803-p1o4qc1h	34	19	practice	practice	VB
cord-026803-p1o4qc1h	34	20	"	"	``
cord-026803-p1o4qc1h	34	21	additional	additional	JJ
cord-026803-p1o4qc1h	34	22	,	,	,
cord-026803-p1o4qc1h	34	23	reasonable	reasonable	JJ
cord-026803-p1o4qc1h	34	24	precautions	precaution	NNS
cord-026803-p1o4qc1h	34	25	"	"	''
cord-026803-p1o4qc1h	34	26	for	for	IN
cord-026803-p1o4qc1h	34	27	those	those	DT
cord-026803-p1o4qc1h	34	28	with	with	IN
cord-026803-p1o4qc1h	34	29	underlying	underlying	JJ
cord-026803-p1o4qc1h	34	30	heart	heart	NN
cord-026803-p1o4qc1h	34	31	disease	disease	NN
cord-026803-p1o4qc1h	34	32	.	.	.
cord-026803-p1o4qc1h	35	1	The	the	DT
cord-026803-p1o4qc1h	35	2	mechanism	mechanism	NN
cord-026803-p1o4qc1h	35	3	of	of	IN
cord-026803-p1o4qc1h	35	4	increased	increase	VBN
cord-026803-p1o4qc1h	35	5	risk	risk	NN
cord-026803-p1o4qc1h	35	6	for	for	IN
cord-026803-p1o4qc1h	35	7	cardiovascular	cardiovascular	JJ
cord-026803-p1o4qc1h	35	8	disease	disease	NN
cord-026803-p1o4qc1h	35	9	patients	patient	NNS
cord-026803-p1o4qc1h	35	10	to	to	IN
cord-026803-p1o4qc1h	35	11	COVID-19	covid-19	VB
cord-026803-p1o4qc1h	35	12	is	be	VBZ
cord-026803-p1o4qc1h	35	13	not	not	RB
cord-026803-p1o4qc1h	35	14	clear	clear	JJ
cord-026803-p1o4qc1h	35	15	.	.	.
cord-026803-p1o4qc1h	36	1	7	7	CD
cord-026803-p1o4qc1h	37	1	The	the	DT
cord-026803-p1o4qc1h	37	2	virus	virus	NN
cord-026803-p1o4qc1h	37	3	penetrates	penetrate	VBZ
cord-026803-p1o4qc1h	37	4	the	the	DT
cord-026803-p1o4qc1h	37	5	cell	cell	NN
cord-026803-p1o4qc1h	37	6	though	though	IN
cord-026803-p1o4qc1h	37	7	the	the	DT
cord-026803-p1o4qc1h	37	8	angiotensin	angiotensin	NN
cord-026803-p1o4qc1h	37	9	-	-	HYPH
cord-026803-p1o4qc1h	37	10	converting	convert	VBG
cord-026803-p1o4qc1h	37	11	enzyme	enzyme	NN
cord-026803-p1o4qc1h	37	12	2	2	CD
cord-026803-p1o4qc1h	37	13	(	(	-LRB-
cord-026803-p1o4qc1h	37	14	ACE2	ACE2	NNP
cord-026803-p1o4qc1h	37	15	)	)	-RRB-
cord-026803-p1o4qc1h	37	16	receptor	receptor	NN
cord-026803-p1o4qc1h	37	17	and	and	CC
cord-026803-p1o4qc1h	37	18	then	then	RB
cord-026803-p1o4qc1h	37	19	multiplies	multiply	VBZ
cord-026803-p1o4qc1h	37	20	to	to	TO
cord-026803-p1o4qc1h	37	21	produce	produce	VB
cord-026803-p1o4qc1h	37	22	the	the	DT
cord-026803-p1o4qc1h	37	23	disease	disease	NN
cord-026803-p1o4qc1h	37	24	.	.	.
cord-026803-p1o4qc1h	38	1	These	these	DT
cord-026803-p1o4qc1h	38	2	receptors	receptor	NNS
cord-026803-p1o4qc1h	38	3	are	be	VBP
cord-026803-p1o4qc1h	38	4	present	present	JJ
cord-026803-p1o4qc1h	38	5	on	on	IN
cord-026803-p1o4qc1h	38	6	epithelial	epithelial	JJ
cord-026803-p1o4qc1h	38	7	cells	cell	NNS
cord-026803-p1o4qc1h	38	8	of	of	IN
cord-026803-p1o4qc1h	38	9	the	the	DT
cord-026803-p1o4qc1h	38	10	lung	lung	NN
cord-026803-p1o4qc1h	38	11	,	,	,
cord-026803-p1o4qc1h	38	12	intestine	intestine	NN
cord-026803-p1o4qc1h	38	13	,	,	,
cord-026803-p1o4qc1h	38	14	kidney	kidney	NN
cord-026803-p1o4qc1h	38	15	,	,	,
cord-026803-p1o4qc1h	38	16	and	and	CC
cord-026803-p1o4qc1h	38	17	blood	blood	NN
cord-026803-p1o4qc1h	38	18	vessels	vessel	NNS
cord-026803-p1o4qc1h	38	19	.	.	.
cord-026803-p1o4qc1h	39	1	8	8	CD
cord-026803-p1o4qc1h	39	2	Patients	patient	NNS
cord-026803-p1o4qc1h	39	3	with	with	IN
cord-026803-p1o4qc1h	39	4	hypertension	hypertension	NN
cord-026803-p1o4qc1h	39	5	and	and	CC
cord-026803-p1o4qc1h	39	6	diabetes	diabetes	NN
cord-026803-p1o4qc1h	39	7	,	,	,
cord-026803-p1o4qc1h	39	8	who	who	WP
cord-026803-p1o4qc1h	39	9	receive	receive	VBP
cord-026803-p1o4qc1h	39	10	angiotensin	angiotensin	NN
cord-026803-p1o4qc1h	39	11	-	-	HYPH
cord-026803-p1o4qc1h	39	12	converting	convert	VBG
cord-026803-p1o4qc1h	39	13	enzyme	enzyme	NN
cord-026803-p1o4qc1h	39	14	inhibitors	inhibitor	NNS
cord-026803-p1o4qc1h	39	15	(	(	-LRB-
cord-026803-p1o4qc1h	39	16	ACEIs	acei	NNS
cord-026803-p1o4qc1h	39	17	)	)	-RRB-
cord-026803-p1o4qc1h	39	18	and	and	CC
cord-026803-p1o4qc1h	39	19	angiotensin	angiotensin	NN
cord-026803-p1o4qc1h	39	20	receptor	receptor	NN
cord-026803-p1o4qc1h	39	21	blockers	blocker	NNS
cord-026803-p1o4qc1h	39	22	(	(	-LRB-
cord-026803-p1o4qc1h	39	23	ARBs	arb	NNS
cord-026803-p1o4qc1h	39	24	)	)	-RRB-
cord-026803-p1o4qc1h	39	25	have	have	VBP
cord-026803-p1o4qc1h	39	26	more	more	JJR
cord-026803-p1o4qc1h	39	27	expression	expression	NN
cord-026803-p1o4qc1h	39	28	of	of	IN
cord-026803-p1o4qc1h	39	29	these	these	DT
cord-026803-p1o4qc1h	39	30	ACE2	ACE2	NNP
cord-026803-p1o4qc1h	39	31	receptors	receptor	NNS
cord-026803-p1o4qc1h	39	32	on	on	IN
cord-026803-p1o4qc1h	39	33	the	the	DT
cord-026803-p1o4qc1h	39	34	target	target	NN
cord-026803-p1o4qc1h	39	35	cells	cell	NNS
cord-026803-p1o4qc1h	39	36	,	,	,
cord-026803-p1o4qc1h	39	37	which	which	WDT
cord-026803-p1o4qc1h	39	38	may	may	MD
cord-026803-p1o4qc1h	39	39	facilitate	facilitate	VB
cord-026803-p1o4qc1h	39	40	the	the	DT
cord-026803-p1o4qc1h	39	41	entry	entry	NN
cord-026803-p1o4qc1h	39	42	of	of	IN
cord-026803-p1o4qc1h	39	43	the	the	DT
cord-026803-p1o4qc1h	39	44	virus	virus	NN
cord-026803-p1o4qc1h	39	45	(	(	-LRB-
cord-026803-p1o4qc1h	39	46	►	►	NFP
cord-026803-p1o4qc1h	39	47	Fig	fig	NN
cord-026803-p1o4qc1h	39	48	.	.	NNP
cord-026803-p1o4qc1h	39	49	1	1	CD
cord-026803-p1o4qc1h	39	50	)	)	-RRB-
cord-026803-p1o4qc1h	39	51	.	.	.
cord-026803-p1o4qc1h	40	1	But	but	CC
cord-026803-p1o4qc1h	40	2	a	a	DT
cord-026803-p1o4qc1h	40	3	similar	similar	JJ
cord-026803-p1o4qc1h	40	4	effect	effect	NN
cord-026803-p1o4qc1h	40	5	is	be	VBZ
cord-026803-p1o4qc1h	40	6	not	not	RB
cord-026803-p1o4qc1h	40	7	seen	see	VBN
cord-026803-p1o4qc1h	40	8	with	with	IN
cord-026803-p1o4qc1h	40	9	calcium	calcium	NN
cord-026803-p1o4qc1h	40	10	channel	channel	NN
cord-026803-p1o4qc1h	40	11	blockers	blocker	NNS
cord-026803-p1o4qc1h	40	12	.	.	.
cord-026803-p1o4qc1h	41	1	Previously	previously	RB
cord-026803-p1o4qc1h	41	2	,	,	,
cord-026803-p1o4qc1h	41	3	acute	acute	JJ
cord-026803-p1o4qc1h	41	4	myocarditis	myocarditis	NN
cord-026803-p1o4qc1h	41	5	and	and	CC
cord-026803-p1o4qc1h	41	6	heart	heart	NN
cord-026803-p1o4qc1h	41	7	failure	failure	NN
cord-026803-p1o4qc1h	41	8	was	be	VBD
cord-026803-p1o4qc1h	41	9	reported	report	VBN
cord-026803-p1o4qc1h	41	10	with	with	IN
cord-026803-p1o4qc1h	41	11	MERS	MERS	NNP
cord-026803-p1o4qc1h	41	12	-	-	HYPH
cord-026803-p1o4qc1h	41	13	CoV.	CoV.	NNP
cord-026803-p1o4qc1h	42	1	As	as	IN
cord-026803-p1o4qc1h	42	2	SARS	SARS	NNP
cord-026803-p1o4qc1h	42	3	-	-	HYPH
cord-026803-p1o4qc1h	42	4	CoV-2	CoV-2	NNP
cord-026803-p1o4qc1h	42	5	and	and	CC
cord-026803-p1o4qc1h	42	6	MERS	MERS	NNP
cord-026803-p1o4qc1h	42	7	-	-	HYPH
cord-026803-p1o4qc1h	42	8	CoV	CoV	NNP
cord-026803-p1o4qc1h	42	9	have	have	VBP
cord-026803-p1o4qc1h	42	10	similar	similar	JJ
cord-026803-p1o4qc1h	42	11	pathogenicity	pathogenicity	NN
cord-026803-p1o4qc1h	42	12	,	,	,
cord-026803-p1o4qc1h	42	13	myocardial	myocardial	JJ
cord-026803-p1o4qc1h	42	14	injury	injury	NN
cord-026803-p1o4qc1h	42	15	caused	cause	VBN
cord-026803-p1o4qc1h	42	16	due	due	IN
cord-026803-p1o4qc1h	42	17	to	to	IN
cord-026803-p1o4qc1h	42	18	SARS	SARS	NNP
cord-026803-p1o4qc1h	42	19	-	-	HYPH
cord-026803-p1o4qc1h	42	20	CoV-2	CoV-2	NNP
cord-026803-p1o4qc1h	42	21	infection	infection	NN
cord-026803-p1o4qc1h	42	22	may	may	MD
cord-026803-p1o4qc1h	42	23	be	be	VB
cord-026803-p1o4qc1h	42	24	immune	immune	JJ
cord-026803-p1o4qc1h	42	25	mediated	mediate	VBN
cord-026803-p1o4qc1h	42	26	through	through	IN
cord-026803-p1o4qc1h	42	27	the	the	DT
cord-026803-p1o4qc1h	42	28	ACE2	ACE2	NNP
cord-026803-p1o4qc1h	42	29	receptor	receptor	NN
cord-026803-p1o4qc1h	42	30	or	or	CC
cord-026803-p1o4qc1h	42	31	cytokine	cytokine	NN
cord-026803-p1o4qc1h	42	32	storm	storm	NN
cord-026803-p1o4qc1h	42	33	and/or	and/or	CC
cord-026803-p1o4qc1h	42	34	hypoxia	hypoxia	NN
cord-026803-p1o4qc1h	42	35	due	due	IN
cord-026803-p1o4qc1h	42	36	to	to	IN
cord-026803-p1o4qc1h	42	37	acute	acute	JJ
cord-026803-p1o4qc1h	42	38	respiratory	respiratory	JJ
cord-026803-p1o4qc1h	42	39	distress	distress	NN
cord-026803-p1o4qc1h	42	40	syndrome	syndrome	NN
cord-026803-p1o4qc1h	42	41	(	(	-LRB-
cord-026803-p1o4qc1h	42	42	ARDS	ARDS	NNP
cord-026803-p1o4qc1h	42	43	)	)	-RRB-
cord-026803-p1o4qc1h	42	44	.	.	.
cord-026803-p1o4qc1h	43	1	9	9	CD
cord-026803-p1o4qc1h	44	1	Added	add	VBN
cord-026803-p1o4qc1h	44	2	myocardial	myocardial	JJ
cord-026803-p1o4qc1h	44	3	damage	damage	NN
cord-026803-p1o4qc1h	44	4	along	along	IN
cord-026803-p1o4qc1h	44	5	with	with	IN
cord-026803-p1o4qc1h	44	6	ARDS	ARDS	NNP
cord-026803-p1o4qc1h	44	7	makes	make	VBZ
cord-026803-p1o4qc1h	44	8	the	the	DT
cord-026803-p1o4qc1h	44	9	patient	patient	NN
cord-026803-p1o4qc1h	44	10	's	's	POS
cord-026803-p1o4qc1h	44	11	prognosis	prognosis	NN
cord-026803-p1o4qc1h	44	12	worse	bad	JJR
cord-026803-p1o4qc1h	44	13	and	and	CC
cord-026803-p1o4qc1h	44	14	treatment	treatment	NN
cord-026803-p1o4qc1h	44	15	becomes	become	VBZ
cord-026803-p1o4qc1h	44	16	difficult	difficult	JJ
cord-026803-p1o4qc1h	44	17	and	and	CC
cord-026803-p1o4qc1h	44	18	complex	complex	JJ
cord-026803-p1o4qc1h	44	19	.	.	.
cord-026803-p1o4qc1h	45	1	During	during	IN
cord-026803-p1o4qc1h	45	2	the	the	DT
cord-026803-p1o4qc1h	45	3	course	course	NN
cord-026803-p1o4qc1h	45	4	of	of	IN
cord-026803-p1o4qc1h	45	5	progression	progression	NN
cord-026803-p1o4qc1h	45	6	of	of	IN
cord-026803-p1o4qc1h	45	7	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	45	8	disease	disease	NN
cord-026803-p1o4qc1h	45	9	,	,	,
cord-026803-p1o4qc1h	45	10	due	due	JJ
cord-026803-p1o4qc1h	45	11	to	to	IN
cord-026803-p1o4qc1h	45	12	intense	intense	JJ
cord-026803-p1o4qc1h	45	13	systemic	systemic	JJ
cord-026803-p1o4qc1h	45	14	inflammatory	inflammatory	JJ
cord-026803-p1o4qc1h	45	15	response	response	NN
cord-026803-p1o4qc1h	45	16	more	more	RBR
cord-026803-p1o4qc1h	45	17	frequent	frequent	JJ
cord-026803-p1o4qc1h	45	18	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	45	19	involvement	involvement	NN
cord-026803-p1o4qc1h	45	20	occurs	occur	VBZ
cord-026803-p1o4qc1h	45	21	.	.	.
cord-026803-p1o4qc1h	46	1	Deaths	death	NNS
cord-026803-p1o4qc1h	46	2	from	from	IN
cord-026803-p1o4qc1h	46	3	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	46	4	are	be	VBP
cord-026803-p1o4qc1h	46	5	due	due	JJ
cord-026803-p1o4qc1h	46	6	to	to	IN
cord-026803-p1o4qc1h	46	7	cytokine	cytokine	JJ
cord-026803-p1o4qc1h	46	8	storm	storm	NN
cord-026803-p1o4qc1h	46	9	syndrome	syndrome	NN
cord-026803-p1o4qc1h	46	10	and	and	CC
cord-026803-p1o4qc1h	46	11	fulminant	fulminant	JJ
cord-026803-p1o4qc1h	46	12	myocarditis	myocarditis	NN
cord-026803-p1o4qc1h	46	13	.	.	.
cord-026803-p1o4qc1h	47	1	Cytokine	cytokine	NN
cord-026803-p1o4qc1h	47	2	storm	storm	NN
cord-026803-p1o4qc1h	47	3	syndrome	syndrome	NN
cord-026803-p1o4qc1h	47	4	culminates	culminate	VBZ
cord-026803-p1o4qc1h	47	5	as	as	IN
cord-026803-p1o4qc1h	47	6	ARDS	ARDS	NNP
cord-026803-p1o4qc1h	47	7	.	.	.
cord-026803-p1o4qc1h	48	1	Fulminant	Fulminant	NNP
cord-026803-p1o4qc1h	48	2	myocarditis	myocarditis	NN
cord-026803-p1o4qc1h	48	3	is	be	VBZ
cord-026803-p1o4qc1h	48	4	primarily	primarily	RB
cord-026803-p1o4qc1h	48	5	caused	cause	VBN
cord-026803-p1o4qc1h	48	6	by	by	IN
cord-026803-p1o4qc1h	48	7	infection	infection	NN
cord-026803-p1o4qc1h	48	8	with	with	IN
cord-026803-p1o4qc1h	48	9	viruses	virus	NNS
cord-026803-p1o4qc1h	48	10	,	,	,
cord-026803-p1o4qc1h	48	11	with	with	IN
cord-026803-p1o4qc1h	48	12	mortality	mortality	NN
cord-026803-p1o4qc1h	48	13	rates	rate	NNS
cord-026803-p1o4qc1h	48	14	as	as	RB
cord-026803-p1o4qc1h	48	15	high	high	JJ
cord-026803-p1o4qc1h	48	16	as	as	IN
cord-026803-p1o4qc1h	48	17	50	50	CD
cord-026803-p1o4qc1h	48	18	to	to	TO
cord-026803-p1o4qc1h	48	19	70	70	CD
cord-026803-p1o4qc1h	48	20	%	%	NN
cord-026803-p1o4qc1h	48	21	.	.	.
cord-026803-p1o4qc1h	49	1	Concern	concern	NN
cord-026803-p1o4qc1h	49	2	about	about	IN
cord-026803-p1o4qc1h	49	3	the	the	DT
cord-026803-p1o4qc1h	49	4	continuation	continuation	NN
cord-026803-p1o4qc1h	49	5	of	of	IN
cord-026803-p1o4qc1h	49	6	ACEIs	acei	NNS
cord-026803-p1o4qc1h	49	7	and	and	CC
cord-026803-p1o4qc1h	49	8	ARBs	arb	NNS
cord-026803-p1o4qc1h	49	9	for	for	IN
cord-026803-p1o4qc1h	49	10	patients	patient	NNS
cord-026803-p1o4qc1h	49	11	who	who	WP
cord-026803-p1o4qc1h	49	12	are	be	VBP
cord-026803-p1o4qc1h	49	13	already	already	RB
cord-026803-p1o4qc1h	49	14	taking	take	VBG
cord-026803-p1o4qc1h	49	15	them	-PRON-	PRP
cord-026803-p1o4qc1h	49	16	was	be	VBD
cord-026803-p1o4qc1h	49	17	discussed	discuss	VBN
cord-026803-p1o4qc1h	49	18	by	by	IN
cord-026803-p1o4qc1h	49	19	different	different	JJ
cord-026803-p1o4qc1h	49	20	hypertensive	hypertensive	JJ
cord-026803-p1o4qc1h	49	21	societies	society	NNS
cord-026803-p1o4qc1h	49	22	.	.	.
cord-026803-p1o4qc1h	50	1	10	10	CD
cord-026803-p1o4qc1h	50	2	Other	other	JJ
cord-026803-p1o4qc1h	50	3	drugs	drug	NNS
cord-026803-p1o4qc1h	50	4	that	that	WDT
cord-026803-p1o4qc1h	50	5	are	be	VBP
cord-026803-p1o4qc1h	50	6	used	use	VBN
cord-026803-p1o4qc1h	50	7	in	in	IN
cord-026803-p1o4qc1h	50	8	CAD	CAD	NNP
cord-026803-p1o4qc1h	50	9	patients	patient	NNS
cord-026803-p1o4qc1h	50	10	like	like	IN
cord-026803-p1o4qc1h	50	11	statins	statin	NNS
cord-026803-p1o4qc1h	50	12	,	,	,
cord-026803-p1o4qc1h	50	13	antiplatelets	antiplatelet	NNS
cord-026803-p1o4qc1h	50	14	,	,	,
cord-026803-p1o4qc1h	50	15	and	and	CC
cord-026803-p1o4qc1h	50	16	β	β	NN
cord-026803-p1o4qc1h	50	17	-	-	HYPH
cord-026803-p1o4qc1h	50	18	blockers	blocker	NNS
cord-026803-p1o4qc1h	50	19	were	be	VBD
cord-026803-p1o4qc1h	50	20	discussed	discuss	VBN
cord-026803-p1o4qc1h	50	21	in	in	IN
cord-026803-p1o4qc1h	50	22	the	the	DT
cord-026803-p1o4qc1h	50	23	webinar	webinar	NN
cord-026803-p1o4qc1h	50	24	jointly	jointly	RB
cord-026803-p1o4qc1h	50	25	released	release	VBN
cord-026803-p1o4qc1h	50	26	by	by	IN
cord-026803-p1o4qc1h	50	27	the	the	DT
cord-026803-p1o4qc1h	50	28	American	American	NNP
cord-026803-p1o4qc1h	50	29	College	College	NNP
cord-026803-p1o4qc1h	50	30	of	of	IN
cord-026803-p1o4qc1h	50	31	Cardiology	Cardiology	NNP
cord-026803-p1o4qc1h	50	32	(	(	-LRB-
cord-026803-p1o4qc1h	50	33	ACC	ACC	NNP
cord-026803-p1o4qc1h	50	34	)	)	-RRB-
cord-026803-p1o4qc1h	50	35	and	and	CC
cord-026803-p1o4qc1h	50	36	Chinese	chinese	JJ
cord-026803-p1o4qc1h	50	37	cardiology	cardiology	NNP
cord-026803-p1o4qc1h	50	38	association	association	NN
cord-026803-p1o4qc1h	50	39	.	.	.
cord-026803-p1o4qc1h	51	1	They	-PRON-	PRP
cord-026803-p1o4qc1h	51	2	recommend	recommend	VBP
cord-026803-p1o4qc1h	51	3	to	to	TO
cord-026803-p1o4qc1h	51	4	continue	continue	VB
cord-026803-p1o4qc1h	51	5	statin	statin	NN
cord-026803-p1o4qc1h	51	6	but	but	CC
cord-026803-p1o4qc1h	51	7	with	with	IN
cord-026803-p1o4qc1h	51	8	close	close	JJ
cord-026803-p1o4qc1h	51	9	monitoring	monitoring	NN
cord-026803-p1o4qc1h	51	10	.	.	.
cord-026803-p1o4qc1h	52	1	Antiplaletes	Antiplaletes	NNP
cord-026803-p1o4qc1h	52	2	and	and	CC
cord-026803-p1o4qc1h	52	3	β	β	NN
cord-026803-p1o4qc1h	52	4	-	-	HYPH
cord-026803-p1o4qc1h	52	5	blockers	blocker	NNS
cord-026803-p1o4qc1h	52	6	are	be	VBP
cord-026803-p1o4qc1h	52	7	also	also	RB
cord-026803-p1o4qc1h	52	8	to	to	TO
cord-026803-p1o4qc1h	52	9	be	be	VB
cord-026803-p1o4qc1h	52	10	continued	continue	VBN
cord-026803-p1o4qc1h	52	11	.	.	.
cord-026803-p1o4qc1h	53	1	If	if	IN
cord-026803-p1o4qc1h	53	2	steroids	steroid	NNS
cord-026803-p1o4qc1h	53	3	are	be	VBP
cord-026803-p1o4qc1h	53	4	required	require	VBN
cord-026803-p1o4qc1h	53	5	for	for	IN
cord-026803-p1o4qc1h	53	6	fulminant	fulminant	JJ
cord-026803-p1o4qc1h	53	7	myocarditis	myocarditis	NN
cord-026803-p1o4qc1h	53	8	,	,	,
cord-026803-p1o4qc1h	53	9	the	the	DT
cord-026803-p1o4qc1h	53	10	dose	dose	NN
cord-026803-p1o4qc1h	53	11	should	should	MD
cord-026803-p1o4qc1h	53	12	be	be	VB
cord-026803-p1o4qc1h	53	13	low	low	JJ
cord-026803-p1o4qc1h	53	14	to	to	TO
cord-026803-p1o4qc1h	53	15	moderate	moderate	VB
cord-026803-p1o4qc1h	53	16	.	.	.
cord-026803-p1o4qc1h	54	1	If	if	IN
cord-026803-p1o4qc1h	54	2	a	a	DT
cord-026803-p1o4qc1h	54	3	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	54	4	patient	patient	NN
cord-026803-p1o4qc1h	54	5	comes	come	VBZ
cord-026803-p1o4qc1h	54	6	with	with	IN
cord-026803-p1o4qc1h	54	7	ST	ST	NNP
cord-026803-p1o4qc1h	54	8	elevation	elevation	NNP
cord-026803-p1o4qc1h	54	9	myocardial	myocardial	JJ
cord-026803-p1o4qc1h	54	10	infaction	infaction	NNP
cord-026803-p1o4qc1h	54	11	(	(	-LRB-
cord-026803-p1o4qc1h	54	12	STMI	STMI	NNP
cord-026803-p1o4qc1h	54	13	)	)	-RRB-
cord-026803-p1o4qc1h	54	14	,	,	,
cord-026803-p1o4qc1h	54	15	then	then	RB
cord-026803-p1o4qc1h	54	16	thrombolysis	thrombolysis	NN
cord-026803-p1o4qc1h	54	17	should	should	MD
cord-026803-p1o4qc1h	54	18	to	to	TO
cord-026803-p1o4qc1h	54	19	be	be	VB
cord-026803-p1o4qc1h	54	20	considered	consider	VBN
cord-026803-p1o4qc1h	54	21	.	.	.
cord-026803-p1o4qc1h	55	1	If	if	IN
cord-026803-p1o4qc1h	55	2	primary	primary	JJ
cord-026803-p1o4qc1h	55	3	percuaneous	percuaneous	JJ
cord-026803-p1o4qc1h	55	4	coronary	coronary	NN
cord-026803-p1o4qc1h	55	5	intervention	intervention	NNP
cord-026803-p1o4qc1h	55	6	(	(	-LRB-
cord-026803-p1o4qc1h	55	7	PCI	PCI	NNP
cord-026803-p1o4qc1h	55	8	)	)	-RRB-
cord-026803-p1o4qc1h	55	9	is	be	VBZ
cord-026803-p1o4qc1h	55	10	required	require	VBN
cord-026803-p1o4qc1h	55	11	then	then	RB
cord-026803-p1o4qc1h	55	12	it	-PRON-	PRP
cord-026803-p1o4qc1h	55	13	is	be	VBZ
cord-026803-p1o4qc1h	55	14	better	well	JJR
cord-026803-p1o4qc1h	55	15	to	to	TO
cord-026803-p1o4qc1h	55	16	do	do	VB
cord-026803-p1o4qc1h	55	17	it	-PRON-	PRP
cord-026803-p1o4qc1h	55	18	in	in	IN
cord-026803-p1o4qc1h	55	19	isolated	isolate	VBN
cord-026803-p1o4qc1h	55	20	cath	cath	NN
cord-026803-p1o4qc1h	55	21	laboratories	laboratory	NNS
cord-026803-p1o4qc1h	55	22	.	.	.
cord-026803-p1o4qc1h	56	1	If	if	IN
cord-026803-p1o4qc1h	56	2	they	-PRON-	PRP
cord-026803-p1o4qc1h	56	3	are	be	VBP
cord-026803-p1o4qc1h	56	4	not	not	RB
cord-026803-p1o4qc1h	56	5	available	available	JJ
cord-026803-p1o4qc1h	56	6	and	and	CC
cord-026803-p1o4qc1h	56	7	mandatory	mandatory	JJ
cord-026803-p1o4qc1h	56	8	to	to	TO
cord-026803-p1o4qc1h	56	9	do	do	VB
cord-026803-p1o4qc1h	56	10	then	then	RB
cord-026803-p1o4qc1h	56	11	minimum	minimum	VB
cord-026803-p1o4qc1h	56	12	central	central	JJ
cord-026803-p1o4qc1h	56	13	air	air	NN
cord-026803-p1o4qc1h	56	14	circulation	circulation	NN
cord-026803-p1o4qc1h	56	15	in	in	IN
cord-026803-p1o4qc1h	56	16	the	the	DT
cord-026803-p1o4qc1h	56	17	cath	cath	NN
cord-026803-p1o4qc1h	56	18	laboratory	laboratory	NN
cord-026803-p1o4qc1h	56	19	.	.	.
cord-026803-p1o4qc1h	57	1	At	at	IN
cord-026803-p1o4qc1h	57	2	present	present	JJ
cord-026803-p1o4qc1h	57	3	we	-PRON-	PRP
cord-026803-p1o4qc1h	57	4	know	know	VBP
cord-026803-p1o4qc1h	57	5	only	only	RB
cord-026803-p1o4qc1h	57	6	about	about	IN
cord-026803-p1o4qc1h	57	7	the	the	DT
cord-026803-p1o4qc1h	57	8	acute	acute	JJ
cord-026803-p1o4qc1h	57	9	course	course	NN
cord-026803-p1o4qc1h	57	10	of	of	IN
cord-026803-p1o4qc1h	57	11	the	the	DT
cord-026803-p1o4qc1h	57	12	disease	disease	NN
cord-026803-p1o4qc1h	57	13	.	.	.
cord-026803-p1o4qc1h	58	1	We	-PRON-	PRP
cord-026803-p1o4qc1h	58	2	need	need	VBP
cord-026803-p1o4qc1h	58	3	to	to	TO
cord-026803-p1o4qc1h	58	4	follow	follow	VB
cord-026803-p1o4qc1h	58	5	these	these	DT
cord-026803-p1o4qc1h	58	6	patients	patient	NNS
cord-026803-p1o4qc1h	58	7	for	for	IN
cord-026803-p1o4qc1h	58	8	long	long	JJ
cord-026803-p1o4qc1h	58	9	-	-	HYPH
cord-026803-p1o4qc1h	58	10	term	term	NN
cord-026803-p1o4qc1h	58	11	effects	effect	NNS
cord-026803-p1o4qc1h	58	12	.	.	.
cord-026803-p1o4qc1h	59	1	SARS	SARS	NNP
cord-026803-p1o4qc1h	59	2	-	-	HYPH
cord-026803-p1o4qc1h	59	3	CoV	CoV	NNP
cord-026803-p1o4qc1h	59	4	-	-	HYPH
cord-026803-p1o4qc1h	59	5	infected	infect	VBN
cord-026803-p1o4qc1h	59	6	patients	patient	NNS
cord-026803-p1o4qc1h	59	7	on	on	IN
cord-026803-p1o4qc1h	59	8	long	long	JJ
cord-026803-p1o4qc1h	59	9	-	-	HYPH
cord-026803-p1o4qc1h	59	10	term	term	NN
cord-026803-p1o4qc1h	59	11	follow	follow	NN
cord-026803-p1o4qc1h	59	12	-	-	HYPH
cord-026803-p1o4qc1h	59	13	up	up	NN
cord-026803-p1o4qc1h	59	14	of	of	IN
cord-026803-p1o4qc1h	59	15	12	12	CD
cord-026803-p1o4qc1h	59	16	years	year	NNS
cord-026803-p1o4qc1h	59	17	showed	show	VBD
cord-026803-p1o4qc1h	59	18	hyperlipidemia	hyperlipidemia	NN
cord-026803-p1o4qc1h	59	19	(	(	-LRB-
cord-026803-p1o4qc1h	59	20	68	68	CD
cord-026803-p1o4qc1h	59	21	%	%	NN
cord-026803-p1o4qc1h	59	22	)	)	-RRB-
cord-026803-p1o4qc1h	59	23	,	,	,
cord-026803-p1o4qc1h	59	24	cardiovascular	cardiovascular	JJ
cord-026803-p1o4qc1h	59	25	system	system	NN
cord-026803-p1o4qc1h	59	26	abnormalities	abnormality	NNS
cord-026803-p1o4qc1h	59	27	(	(	-LRB-
cord-026803-p1o4qc1h	59	28	44	44	CD
cord-026803-p1o4qc1h	59	29	%	%	NN
cord-026803-p1o4qc1h	59	30	)	)	-RRB-
cord-026803-p1o4qc1h	59	31	,	,	,
cord-026803-p1o4qc1h	59	32	and	and	CC
cord-026803-p1o4qc1h	59	33	glucose	glucose	NN
cord-026803-p1o4qc1h	59	34	metabolism	metabolism	NN
cord-026803-p1o4qc1h	59	35	disorders	disorder	NNS
cord-026803-p1o4qc1h	59	36	(	(	-LRB-
cord-026803-p1o4qc1h	59	37	60	60	CD
cord-026803-p1o4qc1h	59	38	%	%	NN
cord-026803-p1o4qc1h	59	39	)	)	-RRB-
cord-026803-p1o4qc1h	59	40	.	.	.
cord-026803-p1o4qc1h	60	1	24	24	CD
cord-026803-p1o4qc1h	61	1	As	as	IN
cord-026803-p1o4qc1h	61	2	SARS	SARS	NNP
cord-026803-p1o4qc1h	61	3	-	-	HYPH
cord-026803-p1o4qc1h	61	4	CoV	CoV	NNP
cord-026803-p1o4qc1h	61	5	2	2	CD
cord-026803-p1o4qc1h	61	6	also	also	RB
cord-026803-p1o4qc1h	61	7	has	have	VBZ
cord-026803-p1o4qc1h	61	8	similar	similar	JJ
cord-026803-p1o4qc1h	61	9	pathogenicity	pathogenicity	NN
cord-026803-p1o4qc1h	61	10	as	as	IN
cord-026803-p1o4qc1h	61	11	SARS	SARS	NNP
cord-026803-p1o4qc1h	61	12	-	-	HYPH
cord-026803-p1o4qc1h	61	13	CoV	CoV	NNP
cord-026803-p1o4qc1h	61	14	,	,	,
cord-026803-p1o4qc1h	61	15	follow	follow	NN
cord-026803-p1o4qc1h	61	16	-	-	HYPH
cord-026803-p1o4qc1h	61	17	up	up	NN
cord-026803-p1o4qc1h	61	18	of	of	IN
cord-026803-p1o4qc1h	61	19	these	these	DT
cord-026803-p1o4qc1h	61	20	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	61	21	patients	patient	NNS
cord-026803-p1o4qc1h	61	22	for	for	IN
cord-026803-p1o4qc1h	61	23	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	61	24	events	event	NNS
cord-026803-p1o4qc1h	61	25	and	and	CC
cord-026803-p1o4qc1h	61	26	altered	alter	VBN
cord-026803-p1o4qc1h	61	27	metabolic	metabolic	JJ
cord-026803-p1o4qc1h	61	28	status	status	NN
cord-026803-p1o4qc1h	61	29	is	be	VBZ
cord-026803-p1o4qc1h	61	30	required	require	VBN
cord-026803-p1o4qc1h	61	31	.	.	.
cord-026803-p1o4qc1h	62	1	With	with	IN
cord-026803-p1o4qc1h	62	2	this	this	DT
cord-026803-p1o4qc1h	62	3	increasing	increase	VBG
cord-026803-p1o4qc1h	62	4	need	need	NN
cord-026803-p1o4qc1h	62	5	for	for	IN
cord-026803-p1o4qc1h	62	6	awareness	awareness	NN
cord-026803-p1o4qc1h	62	7	of	of	IN
cord-026803-p1o4qc1h	62	8	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	62	9	diseases	disease	NNS
cord-026803-p1o4qc1h	62	10	in	in	IN
cord-026803-p1o4qc1h	62	11	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	62	12	,	,	,
cord-026803-p1o4qc1h	62	13	ACC	ACC	NNP
cord-026803-p1o4qc1h	62	14	released	release	VBD
cord-026803-p1o4qc1h	62	15	a	a	DT
cord-026803-p1o4qc1h	62	16	clinical	clinical	JJ
cord-026803-p1o4qc1h	62	17	bulletin	bulletin	NN
cord-026803-p1o4qc1h	62	18	for	for	IN
cord-026803-p1o4qc1h	62	19	the	the	DT
cord-026803-p1o4qc1h	62	20	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	62	21	care	care	NN
cord-026803-p1o4qc1h	62	22	team	team	NN
cord-026803-p1o4qc1h	62	23	.	.	.
cord-026803-p1o4qc1h	63	1	20	20	CD
cord-026803-p1o4qc1h	63	2	Cardiac	Cardiac	NNP
cord-026803-p1o4qc1h	63	3	complications	complication	NNS
cord-026803-p1o4qc1h	63	4	in	in	IN
cord-026803-p1o4qc1h	63	5	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	63	6	simulates	simulate	VBZ
cord-026803-p1o4qc1h	63	7	that	that	DT
cord-026803-p1o4qc1h	63	8	of	of	IN
cord-026803-p1o4qc1h	63	9	SARS	SARS	NNP
cord-026803-p1o4qc1h	63	10	,	,	,
cord-026803-p1o4qc1h	63	11	MERS	MERS	NNP
cord-026803-p1o4qc1h	63	12	,	,	,
cord-026803-p1o4qc1h	63	13	and	and	CC
cord-026803-p1o4qc1h	63	14	influenza	influenza	NN
cord-026803-p1o4qc1h	63	15	.	.	.
cord-026803-p1o4qc1h	64	1	The	the	DT
cord-026803-p1o4qc1h	64	2	cardiologist	cardiologist	NN
cord-026803-p1o4qc1h	64	3	has	have	VBZ
cord-026803-p1o4qc1h	64	4	to	to	TO
cord-026803-p1o4qc1h	64	5	assist	assist	VB
cord-026803-p1o4qc1h	64	6	other	other	JJ
cord-026803-p1o4qc1h	64	7	clinical	clinical	JJ
cord-026803-p1o4qc1h	64	8	specialties	specialty	NNS
cord-026803-p1o4qc1h	64	9	to	to	TO
cord-026803-p1o4qc1h	64	10	manage	manage	VB
cord-026803-p1o4qc1h	64	11	the	the	DT
cord-026803-p1o4qc1h	64	12	cases	case	NNS
cord-026803-p1o4qc1h	64	13	of	of	IN
cord-026803-p1o4qc1h	64	14	COVID-19	covid-19	CD
cord-026803-p1o4qc1h	64	15	with	with	IN
cord-026803-p1o4qc1h	64	16	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	64	17	complications	complication	NNS
cord-026803-p1o4qc1h	64	18	.	.	.
cord-026803-p1o4qc1h	65	1	Echocardiography	echocardiography	NN
cord-026803-p1o4qc1h	65	2	(	(	-LRB-
cord-026803-p1o4qc1h	65	3	ECG	ECG	NNP
cord-026803-p1o4qc1h	65	4	)	)	-RRB-
cord-026803-p1o4qc1h	65	5	should	should	MD
cord-026803-p1o4qc1h	65	6	be	be	VB
cord-026803-p1o4qc1h	65	7	done	do	VBN
cord-026803-p1o4qc1h	65	8	in	in	IN
cord-026803-p1o4qc1h	65	9	patients	patient	NNS
cord-026803-p1o4qc1h	65	10	with	with	IN
cord-026803-p1o4qc1h	65	11	ECG	ECG	NNP
cord-026803-p1o4qc1h	65	12	changes	change	NNS
cord-026803-p1o4qc1h	65	13	and	and	CC
cord-026803-p1o4qc1h	65	14	those	those	DT
cord-026803-p1o4qc1h	65	15	demonstrating	demonstrate	VBG
cord-026803-p1o4qc1h	65	16	heart	heart	NN
cord-026803-p1o4qc1h	65	17	failure	failure	NN
cord-026803-p1o4qc1h	65	18	,	,	,
cord-026803-p1o4qc1h	65	19	arrhythmia	arrhythmia	NN
cord-026803-p1o4qc1h	65	20	,	,	,
cord-026803-p1o4qc1h	65	21	or	or	CC
cord-026803-p1o4qc1h	65	22	cardiomegaly	cardiomegaly	NN
cord-026803-p1o4qc1h	65	23	.	.	.
cord-026803-p1o4qc1h	66	1	Patients	patient	NNS
cord-026803-p1o4qc1h	66	2	with	with	IN
cord-026803-p1o4qc1h	66	3	CVD	CVD	NNP
cord-026803-p1o4qc1h	66	4	are	be	VBP
cord-026803-p1o4qc1h	66	5	at	at	IN
cord-026803-p1o4qc1h	66	6	risk	risk	NN
cord-026803-p1o4qc1h	66	7	of	of	IN
cord-026803-p1o4qc1h	66	8	contracting	contracting	NN
cord-026803-p1o4qc1h	66	9	COVID-19	covid-19	VB
cord-026803-p1o4qc1h	66	10	and	and	CC
cord-026803-p1o4qc1h	66	11	have	have	VBP
cord-026803-p1o4qc1h	66	12	a	a	DT
cord-026803-p1o4qc1h	66	13	worse	bad	JJR
cord-026803-p1o4qc1h	66	14	prognosis	prognosis	NN
cord-026803-p1o4qc1h	66	15	.	.	.
cord-026803-p1o4qc1h	67	1	As	as	IN
cord-026803-p1o4qc1h	67	2	there	there	EX
cord-026803-p1o4qc1h	67	3	is	be	VBZ
cord-026803-p1o4qc1h	67	4	an	an	DT
cord-026803-p1o4qc1h	67	5	increased	increased	JJ
cord-026803-p1o4qc1h	67	6	risk	risk	NN
cord-026803-p1o4qc1h	67	7	of	of	IN
cord-026803-p1o4qc1h	67	8	secondary	secondary	JJ
cord-026803-p1o4qc1h	67	9	infections	infection	NNS
cord-026803-p1o4qc1h	67	10	with	with	IN
cord-026803-p1o4qc1h	67	11	COVID-19	covid-19	CD
cord-026803-p1o4qc1h	67	12	,	,	,
cord-026803-p1o4qc1h	67	13	patients	patient	NNS
cord-026803-p1o4qc1h	67	14	are	be	VBP
cord-026803-p1o4qc1h	67	15	advised	advise	VBN
cord-026803-p1o4qc1h	67	16	to	to	TO
cord-026803-p1o4qc1h	67	17	remain	remain	VB
cord-026803-p1o4qc1h	67	18	current	current	JJ
cord-026803-p1o4qc1h	67	19	with	with	IN
cord-026803-p1o4qc1h	67	20	vaccinations	vaccination	NNS
cord-026803-p1o4qc1h	67	21	,	,	,
cord-026803-p1o4qc1h	67	22	including	include	VBG
cord-026803-p1o4qc1h	67	23	the	the	DT
cord-026803-p1o4qc1h	67	24	pneumococcal	pneumococcal	JJ
cord-026803-p1o4qc1h	67	25	vaccine	vaccine	NN
cord-026803-p1o4qc1h	67	26	and	and	CC
cord-026803-p1o4qc1h	67	27	influenza	influenza	NN
cord-026803-p1o4qc1h	67	28	vaccine	vaccine	NN
cord-026803-p1o4qc1h	67	29	in	in	IN
cord-026803-p1o4qc1h	67	30	accordance	accordance	NN
cord-026803-p1o4qc1h	67	31	with	with	IN
cord-026803-p1o4qc1h	67	32	current	current	JJ
cord-026803-p1o4qc1h	67	33	ACC	ACC	NNP
cord-026803-p1o4qc1h	67	34	/	/	SYM
cord-026803-p1o4qc1h	67	35	American	American	NNP
cord-026803-p1o4qc1h	67	36	Heart	Heart	NNP
cord-026803-p1o4qc1h	67	37	Association	Association	NNP
cord-026803-p1o4qc1h	67	38	(	(	-LRB-
cord-026803-p1o4qc1h	67	39	AHA	AHA	NNP
cord-026803-p1o4qc1h	67	40	)	)	-RRB-
cord-026803-p1o4qc1h	67	41	guidelines	guideline	NNS
cord-026803-p1o4qc1h	67	42	.	.	.
cord-026803-p1o4qc1h	68	1	In	in	IN
cord-026803-p1o4qc1h	68	2	patients	patient	NNS
cord-026803-p1o4qc1h	68	3	with	with	IN
cord-026803-p1o4qc1h	68	4	heart	heart	NN
cord-026803-p1o4qc1h	68	5	failure	failure	NN
cord-026803-p1o4qc1h	68	6	or	or	CC
cord-026803-p1o4qc1h	68	7	volume	volume	NN
cord-026803-p1o4qc1h	68	8	overload	overload	NN
cord-026803-p1o4qc1h	68	9	conditions	condition	NNS
cord-026803-p1o4qc1h	68	10	,	,	,
cord-026803-p1o4qc1h	68	11	fluid	fluid	JJ
cord-026803-p1o4qc1h	68	12	administration	administration	NN
cord-026803-p1o4qc1h	68	13	should	should	MD
cord-026803-p1o4qc1h	68	14	be	be	VB
cord-026803-p1o4qc1h	68	15	carefully	carefully	RB
cord-026803-p1o4qc1h	68	16	monitored	monitor	VBN
cord-026803-p1o4qc1h	68	17	.	.	.
cord-026803-p1o4qc1h	69	1	Strategies	strategy	NNS
cord-026803-p1o4qc1h	69	2	should	should	MD
cord-026803-p1o4qc1h	69	3	include	include	VB
cord-026803-p1o4qc1h	69	4	identifying	identify	VBG
cord-026803-p1o4qc1h	69	5	cardiovascular	cardiovascular	JJ
cord-026803-p1o4qc1h	69	6	patients	patient	NNS
cord-026803-p1o4qc1h	69	7	with	with	IN
cord-026803-p1o4qc1h	69	8	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	69	9	symptoms	symptom	NNS
cord-026803-p1o4qc1h	69	10	from	from	IN
cord-026803-p1o4qc1h	69	11	other	other	JJ
cord-026803-p1o4qc1h	69	12	patients	patient	NNS
cord-026803-p1o4qc1h	69	13	,	,	,
cord-026803-p1o4qc1h	69	14	including	include	VBG
cord-026803-p1o4qc1h	69	15	the	the	DT
cord-026803-p1o4qc1h	69	16	outpatients	outpatient	NNS
cord-026803-p1o4qc1h	69	17	,	,	,
cord-026803-p1o4qc1h	69	18	substituting	substitute	VBG
cord-026803-p1o4qc1h	69	19	telephonic	telephonic	JJ
cord-026803-p1o4qc1h	69	20	or	or	CC
cord-026803-p1o4qc1h	69	21	telehealth	telehealth	NN
cord-026803-p1o4qc1h	69	22	consultations	consultation	NNS
cord-026803-p1o4qc1h	69	23	for	for	IN
cord-026803-p1o4qc1h	69	24	in	in	IN
cord-026803-p1o4qc1h	69	25	-	-	HYPH
cord-026803-p1o4qc1h	69	26	person	person	NN
cord-026803-p1o4qc1h	69	27	reviews	review	NNS
cord-026803-p1o4qc1h	69	28	of	of	IN
cord-026803-p1o4qc1h	69	29	stable	stable	JJ
cord-026803-p1o4qc1h	69	30	CAD	CAD	NNP
cord-026803-p1o4qc1h	69	31	patients	patient	NNS
cord-026803-p1o4qc1h	69	32	in	in	IN
cord-026803-p1o4qc1h	69	33	order	order	NN
cord-026803-p1o4qc1h	69	34	to	to	TO
cord-026803-p1o4qc1h	69	35	prevent	prevent	VB
cord-026803-p1o4qc1h	69	36	possible	possible	JJ
cord-026803-p1o4qc1h	69	37	nosocomial	nosocomial	JJ
cord-026803-p1o4qc1h	69	38	COVID-19	covid-19	CD
cord-026803-p1o4qc1h	69	39	infections	infection	NNS
cord-026803-p1o4qc1h	69	40	.	.	.
cord-026803-p1o4qc1h	70	1	21	21	CD
cord-026803-p1o4qc1h	70	2	Care	Care	NNP
cord-026803-p1o4qc1h	70	3	should	should	MD
cord-026803-p1o4qc1h	70	4	be	be	VB
cord-026803-p1o4qc1h	70	5	taken	take	VBN
cord-026803-p1o4qc1h	70	6	to	to	TO
cord-026803-p1o4qc1h	70	7	avoid	avoid	VB
cord-026803-p1o4qc1h	70	8	underdiagnosis	underdiagnosis	NN
cord-026803-p1o4qc1h	70	9	of	of	IN
cord-026803-p1o4qc1h	70	10	AMI	AMI	NNP
cord-026803-p1o4qc1h	70	11	in	in	IN
cord-026803-p1o4qc1h	70	12	the	the	DT
cord-026803-p1o4qc1h	70	13	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	70	14	setting	setting	NN
cord-026803-p1o4qc1h	70	15	.	.	.
cord-026803-p1o4qc1h	71	1	Based	base	VBN
cord-026803-p1o4qc1h	71	2	on	on	IN
cord-026803-p1o4qc1h	71	3	a	a	DT
cord-026803-p1o4qc1h	71	4	small	small	JJ
cord-026803-p1o4qc1h	71	5	study	study	NN
cord-026803-p1o4qc1h	71	6	of	of	IN
cord-026803-p1o4qc1h	71	7	26	26	CD
cord-026803-p1o4qc1h	71	8	patients	patient	NNS
cord-026803-p1o4qc1h	71	9	in	in	IN
cord-026803-p1o4qc1h	71	10	France	France	NNP
cord-026803-p1o4qc1h	71	11	and	and	CC
cord-026803-p1o4qc1h	71	12	16	16	CD
cord-026803-p1o4qc1h	71	13	nonrandomised	nonrandomise	VBN
cord-026803-p1o4qc1h	71	14	trials	trial	NNS
cord-026803-p1o4qc1h	71	15	,	,	,
cord-026803-p1o4qc1h	71	16	it	-PRON-	PRP
cord-026803-p1o4qc1h	71	17	is	be	VBZ
cord-026803-p1o4qc1h	71	18	believed	believe	VBN
cord-026803-p1o4qc1h	71	19	that	that	IN
cord-026803-p1o4qc1h	71	20	the	the	DT
cord-026803-p1o4qc1h	71	21	time	time	NN
cord-026803-p1o4qc1h	71	22	taken	take	VBN
cord-026803-p1o4qc1h	71	23	to	to	TO
cord-026803-p1o4qc1h	71	24	resolve	resolve	VB
cord-026803-p1o4qc1h	71	25	viral	viral	JJ
cord-026803-p1o4qc1h	71	26	shedding	shedding	NN
cord-026803-p1o4qc1h	71	27	from	from	IN
cord-026803-p1o4qc1h	71	28	COVID-19	covid-19	JJ
cord-026803-p1o4qc1h	71	29	patients	patient	NNS
cord-026803-p1o4qc1h	71	30	is	be	VBZ
cord-026803-p1o4qc1h	71	31	decreased	decrease	VBN
cord-026803-p1o4qc1h	71	32	by	by	IN
cord-026803-p1o4qc1h	71	33	treatment	treatment	NN
cord-026803-p1o4qc1h	71	34	with	with	IN
cord-026803-p1o4qc1h	71	35	hydroxychloroquine	hydroxychloroquine	NN
cord-026803-p1o4qc1h	71	36	alone	alone	JJ
cord-026803-p1o4qc1h	71	37	or	or	CC
cord-026803-p1o4qc1h	71	38	in	in	IN
cord-026803-p1o4qc1h	71	39	combination	combination	NN
cord-026803-p1o4qc1h	71	40	with	with	IN
cord-026803-p1o4qc1h	71	41	Azithromycin	Azithromycin	NNP
cord-026803-p1o4qc1h	71	42	.	.	.
cord-026803-p1o4qc1h	72	1	25	25	CD
cord-026803-p1o4qc1h	73	1	With	with	IN
cord-026803-p1o4qc1h	73	2	raised	raise	VBN
cord-026803-p1o4qc1h	73	3	concerns	concern	NNS
cord-026803-p1o4qc1h	73	4	about	about	IN
cord-026803-p1o4qc1h	73	5	the	the	DT
cord-026803-p1o4qc1h	73	6	increased	increase	VBN
cord-026803-p1o4qc1h	73	7	risk	risk	NN
cord-026803-p1o4qc1h	73	8	of	of	IN
cord-026803-p1o4qc1h	73	9	arrhythmic	arrhythmic	JJ
cord-026803-p1o4qc1h	73	10	death	death	NN
cord-026803-p1o4qc1h	73	11	caused	cause	VBN
cord-026803-p1o4qc1h	73	12	by	by	IN
cord-026803-p1o4qc1h	73	13	QT	qt	NN
cord-026803-p1o4qc1h	73	14	prolongation	prolongation	NN
cord-026803-p1o4qc1h	73	15	associated	associate	VBN
cord-026803-p1o4qc1h	73	16	with	with	IN
cord-026803-p1o4qc1h	73	17	use	use	NN
cord-026803-p1o4qc1h	73	18	of	of	IN
cord-026803-p1o4qc1h	73	19	chloroquine	chloroquine	NN
cord-026803-p1o4qc1h	73	20	,	,	,
cord-026803-p1o4qc1h	73	21	hydroxychloroquine	hydroxychloroquine	NNP
cord-026803-p1o4qc1h	73	22	,	,	,
cord-026803-p1o4qc1h	73	23	or	or	CC
cord-026803-p1o4qc1h	73	24	azithromycine	azithromycine	NNP
cord-026803-p1o4qc1h	73	25	(	(	-LRB-
cord-026803-p1o4qc1h	73	26	alone	alone	RB
cord-026803-p1o4qc1h	73	27	or	or	CC
cord-026803-p1o4qc1h	73	28	in	in	IN
cord-026803-p1o4qc1h	73	29	combination	combination	NN
cord-026803-p1o4qc1h	73	30	)	)	-RRB-
cord-026803-p1o4qc1h	73	31	,	,	,
cord-026803-p1o4qc1h	73	32	hydroxychloroquine	hydroxychloroquine	NNP
cord-026803-p1o4qc1h	73	33	or	or	CC
cord-026803-p1o4qc1h	73	34	chloroquine	chloroquine	NN
cord-026803-p1o4qc1h	73	35	therapy	therapy	NN
cord-026803-p1o4qc1h	73	36	should	should	MD
cord-026803-p1o4qc1h	73	37	occur	occur	VB
cord-026803-p1o4qc1h	73	38	in	in	IN
cord-026803-p1o4qc1h	73	39	the	the	DT
cord-026803-p1o4qc1h	73	40	context	context	NN
cord-026803-p1o4qc1h	73	41	of	of	IN
cord-026803-p1o4qc1h	73	42	a	a	DT
cord-026803-p1o4qc1h	73	43	clinical	clinical	JJ
cord-026803-p1o4qc1h	73	44	trial	trial	NN
cord-026803-p1o4qc1h	73	45	or	or	CC
cord-026803-p1o4qc1h	73	46	registry	registry	NN
cord-026803-p1o4qc1h	73	47	,	,	,
cord-026803-p1o4qc1h	73	48	until	until	IN
cord-026803-p1o4qc1h	73	49	sufficient	sufficient	JJ
cord-026803-p1o4qc1h	73	50	evidence	evidence	NN
cord-026803-p1o4qc1h	73	51	is	be	VBZ
cord-026803-p1o4qc1h	73	52	available	available	JJ
cord-026803-p1o4qc1h	73	53	for	for	IN
cord-026803-p1o4qc1h	73	54	use	use	NN
cord-026803-p1o4qc1h	73	55	in	in	IN
cord-026803-p1o4qc1h	73	56	clinical	clinical	JJ
cord-026803-p1o4qc1h	73	57	practice	practice	NN
cord-026803-p1o4qc1h	73	58	.	.	.
cord-026803-p1o4qc1h	74	1	26	26	CD
cord-026803-p1o4qc1h	75	1	Regarding	regard	VBG
cord-026803-p1o4qc1h	75	2	the	the	DT
cord-026803-p1o4qc1h	75	3	management	management	NN
cord-026803-p1o4qc1h	75	4	of	of	IN
cord-026803-p1o4qc1h	75	5	patients	patient	NNS
cord-026803-p1o4qc1h	75	6	with	with	IN
cord-026803-p1o4qc1h	75	7	ACS	ACS	NNP
cord-026803-p1o4qc1h	75	8	in	in	IN
cord-026803-p1o4qc1h	75	9	the	the	DT
cord-026803-p1o4qc1h	75	10	setting	setting	NN
cord-026803-p1o4qc1h	75	11	of	of	IN
cord-026803-p1o4qc1h	75	12	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	75	13	,	,	,
cord-026803-p1o4qc1h	75	14	SCAI	SCAI	NNP
cord-026803-p1o4qc1h	75	15	consensus	consensus	NN
cord-026803-p1o4qc1h	75	16	is	be	VBZ
cord-026803-p1o4qc1h	75	17	to	to	TO
cord-026803-p1o4qc1h	75	18	preferably	preferably	RB
cord-026803-p1o4qc1h	75	19	take	take	VB
cord-026803-p1o4qc1h	75	20	true	true	JJ
cord-026803-p1o4qc1h	75	21	STEMI	STEMI	NNP
cord-026803-p1o4qc1h	75	22	patients	patient	NNS
cord-026803-p1o4qc1h	75	23	for	for	IN
cord-026803-p1o4qc1h	75	24	primary	primary	JJ
cord-026803-p1o4qc1h	75	25	angioplasty	angioplasty	NN
cord-026803-p1o4qc1h	75	26	and	and	CC
cord-026803-p1o4qc1h	75	27	to	to	TO
cord-026803-p1o4qc1h	75	28	avoid	avoid	VB
cord-026803-p1o4qc1h	75	29	diagnostic	diagnostic	JJ
cord-026803-p1o4qc1h	75	30	or	or	CC
cord-026803-p1o4qc1h	75	31	therapeutic	therapeutic	JJ
cord-026803-p1o4qc1h	75	32	interventions	intervention	NNS
cord-026803-p1o4qc1h	75	33	in	in	IN
cord-026803-p1o4qc1h	75	34	NSTEMI	NSTEMI	NNP
cord-026803-p1o4qc1h	75	35	ACS	ACS	NNP
cord-026803-p1o4qc1h	75	36	patients	patient	NNS
cord-026803-p1o4qc1h	75	37	with	with	IN
cord-026803-p1o4qc1h	75	38	low	low	JJ
cord-026803-p1o4qc1h	75	39	risk	risk	NN
cord-026803-p1o4qc1h	75	40	features	feature	NNS
cord-026803-p1o4qc1h	75	41	.	.	.
cord-026803-p1o4qc1h	76	1	It	-PRON-	PRP
cord-026803-p1o4qc1h	76	2	is	be	VBZ
cord-026803-p1o4qc1h	76	3	also	also	RB
cord-026803-p1o4qc1h	76	4	recommended	recommend	VBN
cord-026803-p1o4qc1h	76	5	to	to	TO
cord-026803-p1o4qc1h	76	6	avoid	avoid	VB
cord-026803-p1o4qc1h	76	7	endotracheal	endotracheal	JJ
cord-026803-p1o4qc1h	76	8	intubation	intubation	NN
cord-026803-p1o4qc1h	76	9	in	in	IN
cord-026803-p1o4qc1h	76	10	the	the	DT
cord-026803-p1o4qc1h	76	11	cath	cath	NN
cord-026803-p1o4qc1h	76	12	lab	lab	NN
cord-026803-p1o4qc1h	76	13	as	as	RB
cord-026803-p1o4qc1h	76	14	much	much	RB
cord-026803-p1o4qc1h	76	15	as	as	IN
cord-026803-p1o4qc1h	76	16	possible	possible	JJ
cord-026803-p1o4qc1h	76	17	,	,	,
cord-026803-p1o4qc1h	76	18	but	but	CC
cord-026803-p1o4qc1h	76	19	if	if	IN
cord-026803-p1o4qc1h	76	20	it	-PRON-	PRP
cord-026803-p1o4qc1h	76	21	must	must	MD
cord-026803-p1o4qc1h	76	22	be	be	VB
cord-026803-p1o4qc1h	76	23	done	do	VBN
cord-026803-p1o4qc1h	76	24	,	,	,
cord-026803-p1o4qc1h	76	25	it	-PRON-	PRP
cord-026803-p1o4qc1h	76	26	is	be	VBZ
cord-026803-p1o4qc1h	76	27	advised	advise	VBN
cord-026803-p1o4qc1h	76	28	to	to	TO
cord-026803-p1o4qc1h	76	29	remove	remove	VB
cord-026803-p1o4qc1h	76	30	all	all	DT
cord-026803-p1o4qc1h	76	31	nonessential	nonessential	JJ
cord-026803-p1o4qc1h	76	32	personnel	personnel	NNS
cord-026803-p1o4qc1h	76	33	from	from	IN
cord-026803-p1o4qc1h	76	34	the	the	DT
cord-026803-p1o4qc1h	76	35	lab	lab	NN
cord-026803-p1o4qc1h	76	36	to	to	TO
cord-026803-p1o4qc1h	76	37	avoid	avoid	VB
cord-026803-p1o4qc1h	76	38	potential	potential	JJ
cord-026803-p1o4qc1h	76	39	exposure	exposure	NN
cord-026803-p1o4qc1h	76	40	to	to	IN
cord-026803-p1o4qc1h	76	41	aerosolized	aerosolize	VBN
cord-026803-p1o4qc1h	76	42	virus	virus	NN
cord-026803-p1o4qc1h	76	43	.	.	.
cord-026803-p1o4qc1h	77	1	For	for	IN
cord-026803-p1o4qc1h	77	2	patients	patient	NNS
cord-026803-p1o4qc1h	77	3	in	in	IN
cord-026803-p1o4qc1h	77	4	respiratory	respiratory	JJ
cord-026803-p1o4qc1h	77	5	distress	distress	NN
cord-026803-p1o4qc1h	77	6	,	,	,
cord-026803-p1o4qc1h	77	7	intubation	intubation	NN
cord-026803-p1o4qc1h	77	8	before	before	IN
cord-026803-p1o4qc1h	77	9	transfer	transfer	NN
cord-026803-p1o4qc1h	77	10	to	to	IN
cord-026803-p1o4qc1h	77	11	the	the	DT
cord-026803-p1o4qc1h	77	12	cath	cath	NN
cord-026803-p1o4qc1h	77	13	lab	lab	NN
cord-026803-p1o4qc1h	77	14	is	be	VBZ
cord-026803-p1o4qc1h	77	15	advised	advise	VBN
cord-026803-p1o4qc1h	77	16	to	to	TO
cord-026803-p1o4qc1h	77	17	avoid	avoid	VB
cord-026803-p1o4qc1h	77	18	aerosolization	aerosolization	NN
cord-026803-p1o4qc1h	77	19	.	.	.
cord-026803-p1o4qc1h	78	1	27	27	CD
cord-026803-p1o4qc1h	79	1	In	in	IN
cord-026803-p1o4qc1h	79	2	conclusion	conclusion	NN
cord-026803-p1o4qc1h	79	3	,	,	,
cord-026803-p1o4qc1h	79	4	the	the	DT
cord-026803-p1o4qc1h	79	5	exact	exact	JJ
cord-026803-p1o4qc1h	79	6	mechanism	mechanism	NN
cord-026803-p1o4qc1h	79	7	through	through	IN
cord-026803-p1o4qc1h	79	8	which	which	WDT
cord-026803-p1o4qc1h	79	9	SARS	SARS	NNP
cord-026803-p1o4qc1h	79	10	-	-	HYPH
cord-026803-p1o4qc1h	79	11	CoV-2	CoV-2	NNP
cord-026803-p1o4qc1h	79	12	causes	cause	VBZ
cord-026803-p1o4qc1h	79	13	COVID-19	covid-19	NN
cord-026803-p1o4qc1h	79	14	is	be	VBZ
cord-026803-p1o4qc1h	79	15	not	not	RB
cord-026803-p1o4qc1h	79	16	known	know	VBN
cord-026803-p1o4qc1h	79	17	;	;	:
cord-026803-p1o4qc1h	79	18	it	-PRON-	PRP
cord-026803-p1o4qc1h	79	19	may	may	MD
cord-026803-p1o4qc1h	79	20	be	be	VB
cord-026803-p1o4qc1h	79	21	through	through	IN
cord-026803-p1o4qc1h	79	22	the	the	DT
cord-026803-p1o4qc1h	79	23	ACE2	ACE2	NNP
cord-026803-p1o4qc1h	79	24	receptors	receptor	NNS
cord-026803-p1o4qc1h	79	25	and	and	CC
cord-026803-p1o4qc1h	79	26	immune	immune	JJ
cord-026803-p1o4qc1h	79	27	mechanism	mechanism	NN
cord-026803-p1o4qc1h	79	28	.	.	.
cord-026803-p1o4qc1h	80	1	SARS	SARS	NNP
cord-026803-p1o4qc1h	80	2	-	-	HYPH
cord-026803-p1o4qc1h	80	3	CoV-2	CoV-2	NNP
cord-026803-p1o4qc1h	80	4	infection	infection	NN
cord-026803-p1o4qc1h	80	5	in	in	IN
cord-026803-p1o4qc1h	80	6	patients	patient	NNS
cord-026803-p1o4qc1h	80	7	with	with	IN
cord-026803-p1o4qc1h	80	8	underlying	underlie	VBG
cord-026803-p1o4qc1h	80	9	CVD	CVD	NNP
cord-026803-p1o4qc1h	80	10	have	have	VB
cord-026803-p1o4qc1h	80	11	worse	bad	JJR
cord-026803-p1o4qc1h	80	12	prognosis	prognosis	NN
cord-026803-p1o4qc1h	80	13	.	.	.
cord-026803-p1o4qc1h	81	1	Cardiovascular	cardiovascular	JJ
cord-026803-p1o4qc1h	81	2	protection	protection	NN
cord-026803-p1o4qc1h	81	3	should	should	MD
cord-026803-p1o4qc1h	81	4	be	be	VB
cord-026803-p1o4qc1h	81	5	given	give	VBN
cord-026803-p1o4qc1h	81	6	attention	attention	NN
cord-026803-p1o4qc1h	81	7	during	during	IN
cord-026803-p1o4qc1h	81	8	the	the	DT
cord-026803-p1o4qc1h	81	9	treatment	treatment	NN
cord-026803-p1o4qc1h	81	10	for	for	IN
cord-026803-p1o4qc1h	81	11	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	81	12	.	.	.
cord-026803-p1o4qc1h	82	1	Emerging	emerge	VBG
cord-026803-p1o4qc1h	82	2	threats	threat	NNS
cord-026803-p1o4qc1h	82	3	from	from	IN
cord-026803-p1o4qc1h	82	4	zoonotic	zoonotic	JJ
cord-026803-p1o4qc1h	82	5	coronaviruses	coronaviruse	NNS
cord-026803-p1o4qc1h	82	6	-	-	:
cord-026803-p1o4qc1h	82	7	from	from	IN
cord-026803-p1o4qc1h	82	8	SARS	SARS	NNP
cord-026803-p1o4qc1h	82	9	and	and	CC
cord-026803-p1o4qc1h	82	10	MERS	MERS	NNP
cord-026803-p1o4qc1h	82	11	to	to	IN
cord-026803-p1o4qc1h	82	12	2019-nCoV	2019-ncov	CD
cord-026803-p1o4qc1h	82	13	Severe	severe	JJ
cord-026803-p1o4qc1h	82	14	acute	acute	JJ
cord-026803-p1o4qc1h	82	15	respiratory	respiratory	JJ
cord-026803-p1o4qc1h	82	16	syndrome	syndrome	NN
cord-026803-p1o4qc1h	82	17	coronavirus	coronavirus	NN
cord-026803-p1o4qc1h	82	18	2	2	CD
cord-026803-p1o4qc1h	83	1	(	(	-LRB-
cord-026803-p1o4qc1h	83	2	SARS	SARS	NNP
cord-026803-p1o4qc1h	83	3	-	-	HYPH
cord-026803-p1o4qc1h	83	4	CoV-2	CoV-2	NNP
cord-026803-p1o4qc1h	83	5	)	)	-RRB-
cord-026803-p1o4qc1h	83	6	and	and	CC
cord-026803-p1o4qc1h	83	7	coronavirus	coronavirus	NN
cord-026803-p1o4qc1h	83	8	disease-2019	disease-2019	NNP
cord-026803-p1o4qc1h	83	9	(	(	-LRB-
cord-026803-p1o4qc1h	83	10	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	83	11	)	)	-RRB-
cord-026803-p1o4qc1h	83	12	:	:	:
cord-026803-p1o4qc1h	84	1	the	the	DT
cord-026803-p1o4qc1h	84	2	epidemic	epidemic	NN
cord-026803-p1o4qc1h	84	3	and	and	CC
cord-026803-p1o4qc1h	84	4	the	the	DT
cord-026803-p1o4qc1h	84	5	challenges	challenge	NNS
cord-026803-p1o4qc1h	84	6	China	China	NNP
cord-026803-p1o4qc1h	84	7	Medical	Medical	NNP
cord-026803-p1o4qc1h	84	8	Treatment	Treatment	NNP
cord-026803-p1o4qc1h	84	9	Expert	Expert	NNP
cord-026803-p1o4qc1h	84	10	Group	Group	NNP
cord-026803-p1o4qc1h	84	11	for	for	IN
cord-026803-p1o4qc1h	84	12	Covid-19	Covid-19	NNP
cord-026803-p1o4qc1h	84	13	.	.	.
cord-026803-p1o4qc1h	85	1	Clinical	clinical	JJ
cord-026803-p1o4qc1h	85	2	characteristics	characteristic	NNS
cord-026803-p1o4qc1h	85	3	of	of	IN
cord-026803-p1o4qc1h	85	4	coronavirus	coronavirus	NN
cord-026803-p1o4qc1h	85	5	disease	disease	NN
cord-026803-p1o4qc1h	85	6	2019	2019	CD
cord-026803-p1o4qc1h	85	7	in	in	IN
cord-026803-p1o4qc1h	85	8	China	China	NNP
cord-026803-p1o4qc1h	86	1	Clinical	clinical	JJ
cord-026803-p1o4qc1h	86	2	course	course	NN
cord-026803-p1o4qc1h	86	3	and	and	CC
cord-026803-p1o4qc1h	86	4	outcomes	outcome	NNS
cord-026803-p1o4qc1h	86	5	of	of	IN
cord-026803-p1o4qc1h	86	6	critically	critically	RB
cord-026803-p1o4qc1h	86	7	ill	ill	JJ
cord-026803-p1o4qc1h	86	8	patients	patient	NNS
cord-026803-p1o4qc1h	86	9	with	with	IN
cord-026803-p1o4qc1h	86	10	SARS	SARS	NNP
cord-026803-p1o4qc1h	86	11	-	-	HYPH
cord-026803-p1o4qc1h	86	12	CoV-2	CoV-2	NNP
cord-026803-p1o4qc1h	86	13	pneumonia	pneumonia	NN
cord-026803-p1o4qc1h	86	14	in	in	IN
cord-026803-p1o4qc1h	86	15	Wuhan	Wuhan	NNP
cord-026803-p1o4qc1h	86	16	,	,	,
cord-026803-p1o4qc1h	86	17	China	China	NNP
cord-026803-p1o4qc1h	86	18	:	:	:
cord-026803-p1o4qc1h	86	19	a	a	DT
cord-026803-p1o4qc1h	86	20	single	single	RB
cord-026803-p1o4qc1h	86	21	-	-	HYPH
cord-026803-p1o4qc1h	86	22	centered	centered	JJ
cord-026803-p1o4qc1h	86	23	,	,	,
cord-026803-p1o4qc1h	86	24	retrospective	retrospective	JJ
cord-026803-p1o4qc1h	86	25	,	,	,
cord-026803-p1o4qc1h	86	26	observational	observational	JJ
cord-026803-p1o4qc1h	86	27	study	study	NN
cord-026803-p1o4qc1h	86	28	Clinical	clinical	JJ
cord-026803-p1o4qc1h	86	29	characteristics	characteristic	NNS
cord-026803-p1o4qc1h	86	30	of	of	IN
cord-026803-p1o4qc1h	86	31	140	140	CD
cord-026803-p1o4qc1h	86	32	patients	patient	NNS
cord-026803-p1o4qc1h	86	33	infected	infect	VBN
cord-026803-p1o4qc1h	86	34	with	with	IN
cord-026803-p1o4qc1h	86	35	SARS	SARS	NNP
cord-026803-p1o4qc1h	86	36	-	-	HYPH
cord-026803-p1o4qc1h	86	37	CoV-2	CoV-2	NNP
cord-026803-p1o4qc1h	86	38	in	in	IN
cord-026803-p1o4qc1h	86	39	Wuhan	Wuhan	NNP
cord-026803-p1o4qc1h	86	40	Comparison	Comparison	NNP
cord-026803-p1o4qc1h	86	41	of	of	IN
cord-026803-p1o4qc1h	86	42	heart	heart	NN
cord-026803-p1o4qc1h	86	43	failure	failure	NN
cord-026803-p1o4qc1h	86	44	and	and	CC
cord-026803-p1o4qc1h	86	45	2019	2019	CD
cord-026803-p1o4qc1h	86	46	novel	novel	JJ
cord-026803-p1o4qc1h	86	47	coronavirus	coronavirus	NN
cord-026803-p1o4qc1h	86	48	pneumonia	pneumonia	NN
cord-026803-p1o4qc1h	86	49	in	in	IN
cord-026803-p1o4qc1h	86	50	chest	chest	NN
cord-026803-p1o4qc1h	86	51	CT	CT	NNP
cord-026803-p1o4qc1h	86	52	features	feature	NNS
cord-026803-p1o4qc1h	86	53	and	and	CC
cord-026803-p1o4qc1h	86	54	clinical	clinical	JJ
cord-026803-p1o4qc1h	86	55	characteristics	characteristic	NNS
cord-026803-p1o4qc1h	87	1	SARS	SARS	NNP
cord-026803-p1o4qc1h	87	2	-	-	HYPH
cord-026803-p1o4qc1h	87	3	CoV-2	CoV-2	NNP
cord-026803-p1o4qc1h	87	4	:	:	:
cord-026803-p1o4qc1h	87	5	a	a	DT
cord-026803-p1o4qc1h	87	6	potential	potential	JJ
cord-026803-p1o4qc1h	87	7	novel	novel	NN
cord-026803-p1o4qc1h	87	8	etiology	etiology	NN
cord-026803-p1o4qc1h	87	9	of	of	IN
cord-026803-p1o4qc1h	87	10	fulminant	fulminant	JJ
cord-026803-p1o4qc1h	87	11	myocarditis	myocarditis	NN
cord-026803-p1o4qc1h	87	12	Receptor	Receptor	NNP
cord-026803-p1o4qc1h	87	13	recognition	recognition	NN
cord-026803-p1o4qc1h	87	14	by	by	IN
cord-026803-p1o4qc1h	87	15	the	the	DT
cord-026803-p1o4qc1h	87	16	novel	novel	JJ
cord-026803-p1o4qc1h	87	17	coronavirus	coronavirus	NN
cord-026803-p1o4qc1h	87	18	from	from	IN
cord-026803-p1o4qc1h	87	19	Wuhan	Wuhan	NNP
cord-026803-p1o4qc1h	87	20	:	:	:
cord-026803-p1o4qc1h	87	21	an	an	DT
cord-026803-p1o4qc1h	87	22	analysis	analysis	NN
cord-026803-p1o4qc1h	87	23	based	base	VBN
cord-026803-p1o4qc1h	87	24	on	on	IN
cord-026803-p1o4qc1h	87	25	decade	decade	NN
cord-026803-p1o4qc1h	87	26	-	-	HYPH
cord-026803-p1o4qc1h	87	27	long	long	JJ
cord-026803-p1o4qc1h	87	28	structural	structural	JJ
cord-026803-p1o4qc1h	87	29	studies	study	NNS
cord-026803-p1o4qc1h	87	30	of	of	IN
cord-026803-p1o4qc1h	87	31	SARS	SARS	NNP
cord-026803-p1o4qc1h	87	32	coronavirus	coronavirus	NN
cord-026803-p1o4qc1h	88	1	A	a	DT
cord-026803-p1o4qc1h	88	2	tug	tug	NN
cord-026803-p1o4qc1h	88	3	-	-	HYPH
cord-026803-p1o4qc1h	88	4	of	of	IN
cord-026803-p1o4qc1h	88	5	-	-	HYPH
cord-026803-p1o4qc1h	88	6	war	war	NN
cord-026803-p1o4qc1h	88	7	between	between	IN
cord-026803-p1o4qc1h	88	8	severe	severe	JJ
cord-026803-p1o4qc1h	88	9	acute	acute	JJ
cord-026803-p1o4qc1h	88	10	respiratory	respiratory	JJ
cord-026803-p1o4qc1h	88	11	syndrome	syndrome	NN
cord-026803-p1o4qc1h	88	12	coronavirus	coronavirus	NN
cord-026803-p1o4qc1h	88	13	2	2	CD
cord-026803-p1o4qc1h	88	14	and	and	CC
cord-026803-p1o4qc1h	88	15	host	host	NN
cord-026803-p1o4qc1h	88	16	antiviral	antiviral	JJ
cord-026803-p1o4qc1h	88	17	defence	defence	NN
cord-026803-p1o4qc1h	88	18	:	:	:
cord-026803-p1o4qc1h	88	19	lessons	lesson	NNS
cord-026803-p1o4qc1h	88	20	from	from	IN
cord-026803-p1o4qc1h	88	21	other	other	JJ
cord-026803-p1o4qc1h	88	22	pathogenic	pathogenic	JJ
cord-026803-p1o4qc1h	88	23	viruses	virus	NNS
cord-026803-p1o4qc1h	88	24	(	(	-LRB-
cord-026803-p1o4qc1h	88	25	CHT)/News	cht)/news	NN
cord-026803-p1o4qc1h	88	26	/	/	SYM
cord-026803-p1o4qc1h	88	27	position	position	NN
cord-026803-p1o4qc1h	88	28	-	-	HYPH
cord-026803-p1o4qc1h	88	29	statement	statement	NN
cord-026803-p1o4qc1h	88	30	-	-	HYPH
cord-026803-p1o4qc1h	88	31	ofthe	ofthe	DT
cord-026803-p1o4qc1h	88	32	-	-	HYPH
cord-026803-p1o4qc1h	88	33	esc	esc	NN
cord-026803-p1o4qc1h	88	34	-	-	HYPH
cord-026803-p1o4qc1h	88	35	council	council	NN
cord-026803-p1o4qc1h	88	36	-	-	HYPH
cord-026803-p1o4qc1h	88	37	on	on	IN
cord-026803-p1o4qc1h	88	38	-	-	HYPH
cord-026803-p1o4qc1h	88	39	hypertension	hypertension	NN
cord-026803-p1o4qc1h	88	40	-	-	HYPH
cord-026803-p1o4qc1h	88	41	on	on	IN
cord-026803-p1o4qc1h	88	42	-	-	HYPH
cord-026803-p1o4qc1h	88	43	ace	ace	NN
cord-026803-p1o4qc1h	88	44	-	-	HYPH
cord-026803-p1o4qc1h	88	45	inhibitors	inhibitor	NNS
cord-026803-p1o4qc1h	88	46	-	-	HYPH
cord-026803-p1o4qc1h	88	47	and	and	CC
cord-026803-p1o4qc1h	88	48	-	-	HYPH
cord-026803-p1o4qc1h	88	49	ang	ang	NNP
cord-026803-p1o4qc1h	88	50	Position	Position	NNP
cord-026803-p1o4qc1h	88	51	statement	statement	NN
cord-026803-p1o4qc1h	88	52	of	of	IN
cord-026803-p1o4qc1h	88	53	the	the	DT
cord-026803-p1o4qc1h	88	54	ESC	ESC	NNP
cord-026803-p1o4qc1h	88	55	Council	Council	NNP
cord-026803-p1o4qc1h	88	56	on	on	IN
cord-026803-p1o4qc1h	88	57	Hypertension	Hypertension	NNP
cord-026803-p1o4qc1h	88	58	on	on	IN
cord-026803-p1o4qc1h	88	59	ACE	ACE	NNP
cord-026803-p1o4qc1h	88	60	-	-	HYPH
cord-026803-p1o4qc1h	88	61	Inhibitors	Inhibitors	NNP
cord-026803-p1o4qc1h	88	62	and	and	CC
cord-026803-p1o4qc1h	88	63	Angiotensin	Angiotensin	NNP
cord-026803-p1o4qc1h	88	64	Receptor	Receptor	NNP
cord-026803-p1o4qc1h	88	65	Blockers	Blockers	NNP
cord-026803-p1o4qc1h	89	1	Hypertension	hypertension	NN
cord-026803-p1o4qc1h	90	1	Canada	Canada	NNP
cord-026803-p1o4qc1h	90	2	's	's	POS
cord-026803-p1o4qc1h	90	3	Statement	statement	NN
cord-026803-p1o4qc1h	90	4	on	on	IN
cord-026803-p1o4qc1h	90	5	.	.	.
cord-026803-p1o4qc1h	91	1	Hypertension	hypertension	NN
cord-026803-p1o4qc1h	91	2	,	,	,
cord-026803-p1o4qc1h	91	3	ACE	ACE	NNP
cord-026803-p1o4qc1h	91	4	-	-	HYPH
cord-026803-p1o4qc1h	91	5	Inhibitors	Inhibitors	NNP
cord-026803-p1o4qc1h	91	6	and	and	CC
cord-026803-p1o4qc1h	91	7	Angiotensin	Angiotensin	NNP
cord-026803-p1o4qc1h	91	8	Receptor	Receptor	NNP
cord-026803-p1o4qc1h	91	9	Blockers	Blockers	NNP
cord-026803-p1o4qc1h	91	10	and	and	CC
cord-026803-p1o4qc1h	91	11	COVID-19	covid-19	VB
cord-026803-p1o4qc1h	91	12	Important	important	JJ
cord-026803-p1o4qc1h	91	13	information	information	NN
cord-026803-p1o4qc1h	91	14	related	relate	VBN
cord-026803-p1o4qc1h	91	15	to	to	IN
cord-026803-p1o4qc1h	91	16	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	91	17	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	91	18	:	:	:
cord-026803-p1o4qc1h	91	19	information	information	NN
cord-026803-p1o4qc1h	91	20	and	and	CC
cord-026803-p1o4qc1h	91	21	guidance	guidance	NN
cord-026803-p1o4qc1h	91	22	for	for	IN
cord-026803-p1o4qc1h	91	23	renal	renal	JJ
cord-026803-p1o4qc1h	91	24	professionals	professional	NNS
cord-026803-p1o4qc1h	91	25	15	15	CD
cord-026803-p1o4qc1h	91	26	International	International	NNP
cord-026803-p1o4qc1h	91	27	Society	Society	NNP
cord-026803-p1o4qc1h	91	28	of	of	IN
cord-026803-p1o4qc1h	91	29	Hypertension	Hypertension	NNP
cord-026803-p1o4qc1h	91	30	.	.	.
cord-026803-p1o4qc1h	92	1	A	a	DT
cord-026803-p1o4qc1h	92	2	statement	statement	NN
cord-026803-p1o4qc1h	92	3	from	from	IN
cord-026803-p1o4qc1h	92	4	the	the	DT
cord-026803-p1o4qc1h	92	5	International	International	NNP
cord-026803-p1o4qc1h	92	6	Society	Society	NNP
cord-026803-p1o4qc1h	92	7	of	of	IN
cord-026803-p1o4qc1h	92	8	Hypertension	Hypertension	NNP
cord-026803-p1o4qc1h	92	9	on	on	IN
cord-026803-p1o4qc1h	92	10	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	92	11	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	92	12	)	)	-RRB-
cord-026803-p1o4qc1h	92	13	:	:	:
cord-026803-p1o4qc1h	92	14	Information	information	NN
cord-026803-p1o4qc1h	92	15	for	for	IN
cord-026803-p1o4qc1h	92	16	internists	internist	NNS
cord-026803-p1o4qc1h	92	17	Urgent	urgent	JJ
cord-026803-p1o4qc1h	92	18	communique	communique	NN
cord-026803-p1o4qc1h	92	19	of	of	IN
cord-026803-p1o4qc1h	92	20	the	the	DT
cord-026803-p1o4qc1h	92	21	seh	seh	NNP
cord-026803-p1o4qc1h	92	22	-	-	HYPH
cord-026803-p1o4qc1h	92	23	lelha	lelha	NNP
cord-026803-p1o4qc1h	92	24	(	(	-LRB-
cord-026803-p1o4qc1h	92	25	Spanish	spanish	JJ
cord-026803-p1o4qc1h	92	26	society	society	NN
cord-026803-p1o4qc1h	92	27	of	of	IN
cord-026803-p1o4qc1h	92	28	hypertension	hypertension	NN
cord-026803-p1o4qc1h	92	29	-	-	HYPH
cord-026803-p1o4qc1h	92	30	Spanish	spanish	JJ
cord-026803-p1o4qc1h	92	31	league	league	NN
cord-026803-p1o4qc1h	92	32	for	for	IN
cord-026803-p1o4qc1h	92	33	the	the	DT
cord-026803-p1o4qc1h	92	34	fight	fight	NN
cord-026803-p1o4qc1h	92	35	against	against	IN
cord-026803-p1o4qc1h	92	36	arterial	arterial	JJ
cord-026803-p1o4qc1h	92	37	hypertension	hypertension	NN
cord-026803-p1o4qc1h	92	38	)	)	-RRB-
cord-026803-p1o4qc1h	92	39	on	on	IN
cord-026803-p1o4qc1h	92	40	the	the	DT
cord-026803-p1o4qc1h	92	41	management	management	NN
cord-026803-p1o4qc1h	92	42	of	of	IN
cord-026803-p1o4qc1h	92	43	the	the	DT
cord-026803-p1o4qc1h	92	44	hypertensive	hypertensive	JJ
cord-026803-p1o4qc1h	92	45	patient	patient	NN
cord-026803-p1o4qc1h	92	46	in	in	IN
cord-026803-p1o4qc1h	92	47	treatment	treatment	NN
cord-026803-p1o4qc1h	92	48	with	with	IN
cord-026803-p1o4qc1h	92	49	drugs	drug	NNS
cord-026803-p1o4qc1h	92	50	that	that	WDT
cord-026803-p1o4qc1h	92	51	block	block	VBP
cord-026803-p1o4qc1h	92	52	the	the	DT
cord-026803-p1o4qc1h	92	53	renina	renina	JJ
cord-026803-p1o4qc1h	92	54	-	-	HYPH
cord-026803-p1o4qc1h	92	55	angiotensin	angiotensin	JJ
cord-026803-p1o4qc1h	92	56	-	-	HYPH
cord-026803-p1o4qc1h	92	57	aldos	aldos	NN
cord-026803-p1o4qc1h	92	58	-	-	HYPH
cord-026803-p1o4qc1h	92	59	aldos	aldos	NN
cord-026803-p1o4qc1h	92	60	system	system	NN
cord-026803-p1o4qc1h	92	61	HFSA	HFSA	NNP
cord-026803-p1o4qc1h	92	62	/	/	SYM
cord-026803-p1o4qc1h	92	63	ACC	ACC	NNP
cord-026803-p1o4qc1h	92	64	/	/	SYM
cord-026803-p1o4qc1h	92	65	AHA	AHA	NNP
cord-026803-p1o4qc1h	92	66	statement	statement	NN
cord-026803-p1o4qc1h	93	1	addresses	address	VBZ
cord-026803-p1o4qc1h	93	2	concerns	concern	NNS
cord-026803-p1o4qc1h	93	3	re	re	IN
cord-026803-p1o4qc1h	93	4	:	:	:
cord-026803-p1o4qc1h	93	5	using	use	VBG
cord-026803-p1o4qc1h	93	6	RAAS	RAAS	NNP
cord-026803-p1o4qc1h	93	7	antagonists	antagonist	NNS
cord-026803-p1o4qc1h	93	8	in	in	IN
cord-026803-p1o4qc1h	93	9	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	93	10	Heart	Heart	NNP
cord-026803-p1o4qc1h	93	11	Failure	Failure	NNP
cord-026803-p1o4qc1h	93	12	Society	Society	NNP
cord-026803-p1o4qc1h	93	13	of	of	IN
cord-026803-p1o4qc1h	93	14	America	America	NNP
cord-026803-p1o4qc1h	93	15	.	.	.
cord-026803-p1o4qc1h	94	1	Patients	patient	NNS
cord-026803-p1o4qc1h	94	2	taking	take	VBG
cord-026803-p1o4qc1h	94	3	ACE	ACE	NNP
cord-026803-p1o4qc1h	94	4	-	-	HYPH
cord-026803-p1o4qc1h	94	5	i	i	PRP
cord-026803-p1o4qc1h	94	6	and	and	CC
cord-026803-p1o4qc1h	94	7	ARBs	ARBs	NNPS
cord-026803-p1o4qc1h	94	8	who	who	WP
cord-026803-p1o4qc1h	94	9	contract	contract	VBP
cord-026803-p1o4qc1h	94	10	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	94	11	should	should	MD
cord-026803-p1o4qc1h	94	12	continue	continue	VB
cord-026803-p1o4qc1h	94	13	treatment	treatment	NN
cord-026803-p1o4qc1h	94	14	,	,	,
cord-026803-p1o4qc1h	94	15	unless	unless	IN
cord-026803-p1o4qc1h	94	16	otherwise	otherwise	RB
cord-026803-p1o4qc1h	94	17	advised	advise	VBN
cord-026803-p1o4qc1h	94	18	by	by	IN
cord-026803-p1o4qc1h	94	19	their	-PRON-	PRP$
cord-026803-p1o4qc1h	94	20	physician	physician	NN
cord-026803-p1o4qc1h	94	21	COVID	COVID	NNP
cord-026803-p1o4qc1h	94	22	-19	-19	XX
cord-026803-p1o4qc1h	95	1	Clinical	clinical	JJ
cord-026803-p1o4qc1h	95	2	Guidance	Guidance	NNP
cord-026803-p1o4qc1h	95	3	for	for	IN
cord-026803-p1o4qc1h	95	4	the	the	DT
cord-026803-p1o4qc1h	95	5	Cardiovascular	Cardiovascular	NNP
cord-026803-p1o4qc1h	95	6	Team	Team	NNP
cord-026803-p1o4qc1h	95	7	22	22	CD
cord-026803-p1o4qc1h	95	8	American	American	NNP
cord-026803-p1o4qc1h	95	9	Society	Society	NNP
cord-026803-p1o4qc1h	95	10	of	of	IN
cord-026803-p1o4qc1h	95	11	Paediatric	Paediatric	NNP
cord-026803-p1o4qc1h	95	12	nephrology	nephrology	NN
cord-026803-p1o4qc1h	95	13	Statement	Statement	NNP
cord-026803-p1o4qc1h	95	14	on	on	IN
cord-026803-p1o4qc1h	95	15	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	95	16	and	and	CC
cord-026803-p1o4qc1h	95	17	blood	blood	NN
cord-026803-p1o4qc1h	95	18	pressure	pressure	NN
cord-026803-p1o4qc1h	95	19	medication	medication	NN
cord-026803-p1o4qc1h	95	20	Altered	alter	VBD
cord-026803-p1o4qc1h	95	21	lipid	lipid	NN
cord-026803-p1o4qc1h	95	22	metabolism	metabolism	NN
cord-026803-p1o4qc1h	95	23	in	in	IN
cord-026803-p1o4qc1h	95	24	recovered	recover	VBN
cord-026803-p1o4qc1h	95	25	SARS	SARS	NNP
cord-026803-p1o4qc1h	95	26	patients	patient	NNS
cord-026803-p1o4qc1h	95	27	twelve	twelve	CD
cord-026803-p1o4qc1h	95	28	years	year	NNS
cord-026803-p1o4qc1h	95	29	after	after	IN
cord-026803-p1o4qc1h	95	30	infection	infection	NN
cord-026803-p1o4qc1h	95	31	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-026803-p1o4qc1h	95	32	and	and	CC
cord-026803-p1o4qc1h	95	33	azithromycin	azithromycin	NNP
cord-026803-p1o4qc1h	95	34	as	as	IN
cord-026803-p1o4qc1h	95	35	a	a	DT
cord-026803-p1o4qc1h	95	36	treatment	treatment	NN
cord-026803-p1o4qc1h	95	37	of	of	IN
cord-026803-p1o4qc1h	95	38	COVID-19	covid-19	NN
cord-026803-p1o4qc1h	95	39	:	:	:
cord-026803-p1o4qc1h	95	40	results	result	NNS
cord-026803-p1o4qc1h	95	41	of	of	IN
cord-026803-p1o4qc1h	95	42	an	an	DT
cord-026803-p1o4qc1h	95	43	open	open	JJ
cord-026803-p1o4qc1h	95	44	-	-	HYPH
cord-026803-p1o4qc1h	95	45	label	label	NN
cord-026803-p1o4qc1h	95	46	non	non	JJ
cord-026803-p1o4qc1h	95	47	-	-	JJ
cord-026803-p1o4qc1h	95	48	randomized	randomized	JJ
cord-026803-p1o4qc1h	95	49	clinical	clinical	JJ
cord-026803-p1o4qc1h	95	50	trial	trial	NN
cord-026803-p1o4qc1h	95	51	Ventricular	Ventricular	NNP
cord-026803-p1o4qc1h	95	52	Arrhythmia	Arrhythmia	NNP
cord-026803-p1o4qc1h	95	53	Risk	risk	NN
cord-026803-p1o4qc1h	96	1	Due	due	IN
cord-026803-p1o4qc1h	96	2	to	to	IN
cord-026803-p1o4qc1h	96	3	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-026803-p1o4qc1h	96	4	-	-	HYPH
cord-026803-p1o4qc1h	96	5	Azithromycin	Azithromycin	NNP
cord-026803-p1o4qc1h	96	6	Treatment	Treatment	NNP
cord-026803-p1o4qc1h	96	7	For	for	IN
cord-026803-p1o4qc1h	96	8	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	96	9	Considerations	Considerations	NNPS
cord-026803-p1o4qc1h	96	10	for	for	IN
cord-026803-p1o4qc1h	96	11	cardiac	cardiac	JJ
cord-026803-p1o4qc1h	96	12	catheterization	catheterization	NN
cord-026803-p1o4qc1h	96	13	laboratory	laboratory	NN
cord-026803-p1o4qc1h	96	14	procedures	procedure	NNS
cord-026803-p1o4qc1h	96	15	during	during	IN
cord-026803-p1o4qc1h	96	16	the	the	DT
cord-026803-p1o4qc1h	96	17	COVID-19	COVID-19	NNP
cord-026803-p1o4qc1h	96	18	pandemic	pandemic	NN
cord-026803-p1o4qc1h	96	19	None	none	NN
cord-026803-p1o4qc1h	96	20	declared	declare	VBD